76 results on '"Heilmann, S."'
Search Results
2. Genome-wide significant risk factors for Alzheimerʼs disease: role in progression to dementia due to Alzheimerʼs disease among subjects with mild cognitive impairment
- Author
-
Lacour, A, Espinosa, A, Louwersheimer, E, Heilmann, S, Hernández, I, Wolfsgruber, S, Fernández, V, Wagner, H, Rosende-Roca, M, Mauleón, A, Moreno-Grau, S, Vargas, L, Pijnenburg, Y AL, Koene, T, Rodríguez-Gómez, O, Ortega, G, Ruiz, S, Holstege, H, Sotolongo-Grau, O, Kornhuber, J, Peters, O, Frölich, L, Hüll, M, Rüther, E, Wiltfang, J, Scherer, M, Riedel-Heller, S, Alegret, M, Nöthen, M M, Scheltens, P, Wagner, M, Tárraga, L, Jessen, F, Boada, M, Maier, W, van der Flier, W M, Becker, T, Ramirez, A, and Ruiz, A
- Published
- 2017
- Full Text
- View/download PDF
3. The effectiveness of the Inspiring Futures parenting programme in improving behavioural and emotional outcomes in primary school children with behavioural or emotional difficulties
- Author
-
Axford, N. (Nick), Warner, G. (Georgina), Hobbs, T. (Tim), Heilmann, S. (Sarah), Raja, A. (Anam), Berry, V. (Vashti), Ukoumunne, O.C. (Obioha C.), Matthews, J. (Justin), Eames, T. (Tim), Kallitsoglou, A. (Angeliki), Blower, S. (Sarah), Wilkinson, T. (Tom), Timmons, L. (Luke), Bjornstad, G. (Gretchen), Axford, N. (Nick), Warner, G. (Georgina), Hobbs, T. (Tim), Heilmann, S. (Sarah), Raja, A. (Anam), Berry, V. (Vashti), Ukoumunne, O.C. (Obioha C.), Matthews, J. (Justin), Eames, T. (Tim), Kallitsoglou, A. (Angeliki), Blower, S. (Sarah), Wilkinson, T. (Tom), Timmons, L. (Luke), and Bjornstad, G. (Gretchen)
- Abstract
Background: There is a need to build the evidence base of early interventions promoting children's health and development in the UK. Malachi Specialist Family Support Services ('Malachi') is a voluntary sector organisation based in the UK that delivers a therapeutic parenting group programme called Inspiring Futures to parents of children identified as having behavioural and emotional difficulties. The programme comprises two parts, delivered sequentially: (1) a group-based programme for all parents for 10-12 weeks, and (2) one-to-one sessions with selected parents from the group-based element for up to 12 weeks. Methods/design: A randomised controlled trial will be conducted to evaluate Malachi's Inspiring Futures parenting programme. Participants will be allocated to one of two possible arms, with follow-up measures at 16 weeks (post-parent group programme) and at 32 weeks (post-one-to-one sessions with selected parents). The sample size is 248 participants with a randomisation allocation ratio of 1:1. The intervention arm will be offered the Inspiring Futures programme. The control group will receive services as usual. The aim is to determine the effectiveness of the Inspiring Futures programme on the primary outcome of behavioural and emotional difficulties of primary school children identified as having behavioural or emotional difficulties. Discussion: This study will further enhance the evidence for early intervention parenting programmes for child behavioural and emotional problems in the UK.
- Published
- 2018
- Full Text
- View/download PDF
4. The effectiveness of the Inspiring Futures parenting programme in improving behavioural and emotional outcomes in primary school children with behavioural or emotional difficulties: study protocol for a randomised controlled trial.
- Author
-
Axford, N, Warner, G, Hobbs, T, Heilmann, S, Raja, A, Berry, V, Ukoumunne, OC, Matthews, J, Eames, T, Kallitsoglou, A, Blower, S, Wilkinson, T, Timmons, L, Bjornstad, G, Axford, N, Warner, G, Hobbs, T, Heilmann, S, Raja, A, Berry, V, Ukoumunne, OC, Matthews, J, Eames, T, Kallitsoglou, A, Blower, S, Wilkinson, T, Timmons, L, and Bjornstad, G
- Abstract
BACKGROUND: There is a need to build the evidence base of early interventions promoting children's health and development in the UK. Malachi Specialist Family Support Services ('Malachi') is a voluntary sector organisation based in the UK that delivers a therapeutic parenting group programme called Inspiring Futures to parents of children identified as having behavioural and emotional difficulties. The programme comprises two parts, delivered sequentially: (1) a group-based programme for all parents for 10-12 weeks, and (2) one-to-one sessions with selected parents from the group-based element for up to 12 weeks. METHODS/DESIGN: A randomised controlled trial will be conducted to evaluate Malachi's Inspiring Futures parenting programme. Participants will be allocated to one of two possible arms, with follow-up measures at 16 weeks (post-parent group programme) and at 32 weeks (post-one-to-one sessions with selected parents). The sample size is 248 participants with a randomisation allocation ratio of 1:1. The intervention arm will be offered the Inspiring Futures programme. The control group will receive services as usual. The aim is to determine the effectiveness of the Inspiring Futures programme on the primary outcome of behavioural and emotional difficulties of primary school children identified as having behavioural or emotional difficulties. DISCUSSION: This study will further enhance the evidence for early intervention parenting programmes for child behavioural and emotional problems in the UK. TRIAL REGISTRATION: Current Controlled Trials ISRCTN32083735 . Retrospectively registered 28 October 2014.
- Published
- 2018
5. Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes
- Author
-
Pulit, SL, Weng, L-C, McArdle, PF, Trinquart, L, Choi, SH, Mitchell, BD, Rosand, J, de Bakker, PIW, Benjamin, EJ, Ellinor, PT, Kittner, SJ, Lubitz, SA, Anderson, CD, Christophersen, IE, Rienstra, M, Roselli, C, Yin, X, Geelhoed, B, Barnard, J, Lin, H, Arking, DE, Smith, A, Albert, CM, Chaffin, M, Tucker, NR, Li, M, Klarin, D, Bihlmeyer, NA, Low, S-K, Weeke, PE, Mueller-Nurasyid, M, Smith, JG, Brody, JA, Niemeijer, MN, Doerr, M, Trompet, S, Huffman, J, Gustafsson, S, Schurmann, C, Kleber, ME, Lyytikainen, L-P, Seppala, I, Malik, R, Horimoto, ARVR, Perez, M, Sinisalo, J, Aeschbacher, S, Theriault, S, Yao, J, Radmanesh, F, Weiss, S, Teumer, A, Clauss, S, Deo, R, Rader, DJ, Shah, S, Sun, A, Hopewell, JC, Debette, S, Chauhan, G, Yang, Q, Worrall, BB, Pare, G, Kamatani, Y, Hagemeijer, YP, Verweij, N, Siland, JE, Kubo, M, Smith, JD, Van Wagoner, DR, Bis, JC, Perz, S, Psaty, BM, Ridker, PM, Magnani, JW, Harris, TB, Launer, LJ, Shoemaker, MB, Padmanabhan, S, Haessler, J, Bartz, TM, Waldenberger, M, Lichtner, P, Arendt, M, Krieger, JE, Kahonen, M, Risch, L, Mansur, AJ, Peters, A, Smith, BH, Lind, L, Scott, SA, Lu, Y, Bottinger, EB, Hernesniemi, J, Lindgren, CM, Wong, JA, Huang, J, Eskola, M, Morris, AP, Ford, I, Reiner, AP, Delgado, G, Chen, LY, Chen, Y-DI, Sandhu, RK, Boerwinkle, E, Eisele, L, Lannfelt, L, Rost, N, Taylor, KD, Campbell, A, Magnusson, PK, Porteous, D, Hocking, LJ, Vlachopoulou, E, Pedersen, NL, Nikus, K, Orho-Melander, M, Hamsten, A, Heeringa, J, Denny, JC, Kriebel, J, Darbar, D, Newton-Cheh, C, Shaffer, C, Macfarlane, PW, Heilmann, S, Almgren, P, Huang, PL, Sotoodehnia, N, Soliman, EZ, Uitterlinden, AG, Hofman, A, Franco, OH, Voelker, U, Joeckel, K-H, Sinner, MF, Lin, HJ, Guo, X, Dichgans, M, Ingelsson, E, Kooperberg, C, Melander, O, Loos, RJF, Laurikka, J, Conen, D, van der Harst, P, Lokki, M-L, Kathiresan, S, Pereira, A, Jukema, JW, Hayward, C, Rotter, J, Maerz, W, Lehtimaki, T, Stricker, BH, Chung, MK, Felix, SB, Gudnason, V, Alonso, A, Roden, DM, Kaeaeb, S, Chasman, D, Heckbert, SR, Tanaka, T, Lunetta, KL, Smoller, S, Sorkin, J, Wang, X, Selim, M, Pikula, A, Wolf, P, Seshadri, S, de Bakker, P, Rexrode, K, Chen, I, Luke, M, Sale, M, Lee, T-H, Chang, K-C, Elkind, M, Goldstein, L, James, ML, Breteler, M, O'Donnell, C, Leys, D, Carty, C, Kidwell, C, Olesen, J, Sharma, P, Rich, S, Tatlisumak, T, Happola, O, Bijlenga, P, Soriano, C, Giralt, E, Roquer, J, Jimenez-Conde, J, Cotlarcius, I, Hardy, J, Korostynski, M, Boncoraglio, G, Ballabio, E, Parati, E, Mateusz, A, Urbanik, A, Dziedzic, T, Jagiella, J, Gasowski, J, Wnuk, M, Olszanecki, R, Pera, J, Slowik, A, Juchniewicz, KJ, Levi, C, Nyquist, P, Cendes, I, Cabral, N, Franca, P, Goncalves, A, Keller, L, Crisby, M, Kostulas, K, Lemmens, R, Ahmadi, K, Opherk, C, Duering, M, Gonik, M, Staals, J, Burri, P, Sadr-Nabavi, A, Romero, J, Biffi, A, Anderson, C, Falcone, G, Brouwers, B, Du, R, Kourkoulis, C, Battey, T, Lubitz, S, Mueller-Myhsok, B, Meschia, J, Brott, T, Pichler, A, Enzinger, C, Schmidt, H, Schmidt, R, Seiler, S, Blanton, S, Yamada, Y, Bersano, A, Rundek, T, Sacco, R, Chan, Y-FY, Gschwendtner, A, Deng, Z, Barr, T, Gwinn, K, Corriveau, R, Singleton, A, Waddy, S, Launer, L, Chen, C, Le, KE, Lee, WL, Tan, EK, Olugbodi, A, Rothwell, P, Schilling, S, Mok, V, Lebedeva, E, Jern, C, Jood, K, Olsson, S, Kim, H, Lee, C, Kilarski, L, Markus, H, Peycke, J, Bevan, S, Sheu, W, Chiou, HY, Chern, J, Giraldo, E, Taqi, M, Jain, V, Lam, O, Howard, G, Woo, D, Kittner, S, Mitchell, B, Cole, J, O'Connell, J, Milewicz, D, Illoh, K, Worrall, B, Stine, C, Karaszewski, B, Werring, D, Sofat, R, Smalley, J, Lindgren, A, Hansen, B, Norrving, B, Smith, G, Jose Martin, J, Thijs, V, Klijn, K, van't Hof, F, Algra, A, Macleod, M, Perry, R, Arnett, D, Pezzini, A, Padovani, A, Cramer, S, Fisher, M, Saleheen, D, Broderick, J, Kissela, B, Doney, A, Sudlow, C, Rannikmae, K, Silliman, S, McDonough, C, Walters, M, Pedersen, A, Nakagawa, K, Chang, C, Dobbins, M, McArdle, P, Chang, Y-C, Brown, R, Brown, D, Holliday, E, Kalaria, R, Maguire, J, Attia, J, Farrall, M, Giese, A-K, Fornage, M, Majersik, J, Cushman, M, Keene, K, Bennett, S, Tirschwell, D, Psaty, B, Reiner, A, Longstreth, W, Spence, D, Montaner, J, Fernandez-Cadenas, I, Langefeld, C, Bushnell, C, Heitsch, L, Lee, J-M, Sheth, K, Pulit, SL, Weng, L-C, McArdle, PF, Trinquart, L, Choi, SH, Mitchell, BD, Rosand, J, de Bakker, PIW, Benjamin, EJ, Ellinor, PT, Kittner, SJ, Lubitz, SA, Anderson, CD, Christophersen, IE, Rienstra, M, Roselli, C, Yin, X, Geelhoed, B, Barnard, J, Lin, H, Arking, DE, Smith, A, Albert, CM, Chaffin, M, Tucker, NR, Li, M, Klarin, D, Bihlmeyer, NA, Low, S-K, Weeke, PE, Mueller-Nurasyid, M, Smith, JG, Brody, JA, Niemeijer, MN, Doerr, M, Trompet, S, Huffman, J, Gustafsson, S, Schurmann, C, Kleber, ME, Lyytikainen, L-P, Seppala, I, Malik, R, Horimoto, ARVR, Perez, M, Sinisalo, J, Aeschbacher, S, Theriault, S, Yao, J, Radmanesh, F, Weiss, S, Teumer, A, Clauss, S, Deo, R, Rader, DJ, Shah, S, Sun, A, Hopewell, JC, Debette, S, Chauhan, G, Yang, Q, Worrall, BB, Pare, G, Kamatani, Y, Hagemeijer, YP, Verweij, N, Siland, JE, Kubo, M, Smith, JD, Van Wagoner, DR, Bis, JC, Perz, S, Psaty, BM, Ridker, PM, Magnani, JW, Harris, TB, Launer, LJ, Shoemaker, MB, Padmanabhan, S, Haessler, J, Bartz, TM, Waldenberger, M, Lichtner, P, Arendt, M, Krieger, JE, Kahonen, M, Risch, L, Mansur, AJ, Peters, A, Smith, BH, Lind, L, Scott, SA, Lu, Y, Bottinger, EB, Hernesniemi, J, Lindgren, CM, Wong, JA, Huang, J, Eskola, M, Morris, AP, Ford, I, Reiner, AP, Delgado, G, Chen, LY, Chen, Y-DI, Sandhu, RK, Boerwinkle, E, Eisele, L, Lannfelt, L, Rost, N, Taylor, KD, Campbell, A, Magnusson, PK, Porteous, D, Hocking, LJ, Vlachopoulou, E, Pedersen, NL, Nikus, K, Orho-Melander, M, Hamsten, A, Heeringa, J, Denny, JC, Kriebel, J, Darbar, D, Newton-Cheh, C, Shaffer, C, Macfarlane, PW, Heilmann, S, Almgren, P, Huang, PL, Sotoodehnia, N, Soliman, EZ, Uitterlinden, AG, Hofman, A, Franco, OH, Voelker, U, Joeckel, K-H, Sinner, MF, Lin, HJ, Guo, X, Dichgans, M, Ingelsson, E, Kooperberg, C, Melander, O, Loos, RJF, Laurikka, J, Conen, D, van der Harst, P, Lokki, M-L, Kathiresan, S, Pereira, A, Jukema, JW, Hayward, C, Rotter, J, Maerz, W, Lehtimaki, T, Stricker, BH, Chung, MK, Felix, SB, Gudnason, V, Alonso, A, Roden, DM, Kaeaeb, S, Chasman, D, Heckbert, SR, Tanaka, T, Lunetta, KL, Smoller, S, Sorkin, J, Wang, X, Selim, M, Pikula, A, Wolf, P, Seshadri, S, de Bakker, P, Rexrode, K, Chen, I, Luke, M, Sale, M, Lee, T-H, Chang, K-C, Elkind, M, Goldstein, L, James, ML, Breteler, M, O'Donnell, C, Leys, D, Carty, C, Kidwell, C, Olesen, J, Sharma, P, Rich, S, Tatlisumak, T, Happola, O, Bijlenga, P, Soriano, C, Giralt, E, Roquer, J, Jimenez-Conde, J, Cotlarcius, I, Hardy, J, Korostynski, M, Boncoraglio, G, Ballabio, E, Parati, E, Mateusz, A, Urbanik, A, Dziedzic, T, Jagiella, J, Gasowski, J, Wnuk, M, Olszanecki, R, Pera, J, Slowik, A, Juchniewicz, KJ, Levi, C, Nyquist, P, Cendes, I, Cabral, N, Franca, P, Goncalves, A, Keller, L, Crisby, M, Kostulas, K, Lemmens, R, Ahmadi, K, Opherk, C, Duering, M, Gonik, M, Staals, J, Burri, P, Sadr-Nabavi, A, Romero, J, Biffi, A, Anderson, C, Falcone, G, Brouwers, B, Du, R, Kourkoulis, C, Battey, T, Lubitz, S, Mueller-Myhsok, B, Meschia, J, Brott, T, Pichler, A, Enzinger, C, Schmidt, H, Schmidt, R, Seiler, S, Blanton, S, Yamada, Y, Bersano, A, Rundek, T, Sacco, R, Chan, Y-FY, Gschwendtner, A, Deng, Z, Barr, T, Gwinn, K, Corriveau, R, Singleton, A, Waddy, S, Launer, L, Chen, C, Le, KE, Lee, WL, Tan, EK, Olugbodi, A, Rothwell, P, Schilling, S, Mok, V, Lebedeva, E, Jern, C, Jood, K, Olsson, S, Kim, H, Lee, C, Kilarski, L, Markus, H, Peycke, J, Bevan, S, Sheu, W, Chiou, HY, Chern, J, Giraldo, E, Taqi, M, Jain, V, Lam, O, Howard, G, Woo, D, Kittner, S, Mitchell, B, Cole, J, O'Connell, J, Milewicz, D, Illoh, K, Worrall, B, Stine, C, Karaszewski, B, Werring, D, Sofat, R, Smalley, J, Lindgren, A, Hansen, B, Norrving, B, Smith, G, Jose Martin, J, Thijs, V, Klijn, K, van't Hof, F, Algra, A, Macleod, M, Perry, R, Arnett, D, Pezzini, A, Padovani, A, Cramer, S, Fisher, M, Saleheen, D, Broderick, J, Kissela, B, Doney, A, Sudlow, C, Rannikmae, K, Silliman, S, McDonough, C, Walters, M, Pedersen, A, Nakagawa, K, Chang, C, Dobbins, M, McArdle, P, Chang, Y-C, Brown, R, Brown, D, Holliday, E, Kalaria, R, Maguire, J, Attia, J, Farrall, M, Giese, A-K, Fornage, M, Majersik, J, Cushman, M, Keene, K, Bennett, S, Tirschwell, D, Psaty, B, Reiner, A, Longstreth, W, Spence, D, Montaner, J, Fernandez-Cadenas, I, Langefeld, C, Bushnell, C, Heitsch, L, Lee, J-M, and Sheth, K
- Abstract
OBJECTIVE: We sought to assess whether genetic risk factors for atrial fibrillation (AF) can explain cardioembolic stroke risk. METHODS: We evaluated genetic correlations between a previous genetic study of AF and AF in the presence of cardioembolic stroke using genome-wide genotypes from the Stroke Genetics Network (N = 3,190 AF cases, 3,000 cardioembolic stroke cases, and 28,026 referents). We tested whether a previously validated AF polygenic risk score (PRS) associated with cardioembolic and other stroke subtypes after accounting for AF clinical risk factors. RESULTS: We observed a strong correlation between previously reported genetic risk for AF, AF in the presence of stroke, and cardioembolic stroke (Pearson r = 0.77 and 0.76, respectively, across SNPs with p < 4.4 × 10-4 in the previous AF meta-analysis). An AF PRS, adjusted for clinical AF risk factors, was associated with cardioembolic stroke (odds ratio [OR] per SD = 1.40, p = 1.45 × 10-48), explaining ∼20% of the heritable component of cardioembolic stroke risk. The AF PRS was also associated with stroke of undetermined cause (OR per SD = 1.07, p = 0.004), but no other primary stroke subtypes (all p > 0.1). CONCLUSIONS: Genetic risk of AF is associated with cardioembolic stroke, independent of clinical risk factors. Studies are warranted to determine whether AF genetic risk can serve as a biomarker for strokes caused by AF.
- Published
- 2018
6. Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease
- Author
-
Webb, T.R., Erdmann, J., Stirrups, K.E., Stitziel, N.O., Masca, N.G.D., Jansen, H., Kanoni, S., Nelson, C.P., Ferrario, P.G., Konig, I.R., Eicher, J.D., Johnson, A.D., Hamby, S.E., Betsholtz, C., Ruusalepp, A., Franzen, O., Schadt, E.E., Bjorkegren, J.L.M., Weeke, P.E., Auer, P.L., Schick, U.M., Lu, Y.C., Zhang, H., Dube, M.P., Goel, A., Farrall, M., Peloso, G.M., Won, H.H., R. do, Iperen, E. van, Kruppa, J., Mahajan, A., Scott, R.A., Willenborg, C., Braund, P.S., Capelleveen, J.C. van, Doney, A.S.F., Donnelly, L.A., Asselta, R., Merlini, P.A., Duga, S., Marziliano, N., Denny, J.C., Shaffer, C., El-Mokhtari, N.E., Franke, A., Heilmann, S., Hengstenberg, C., Hoffmann, P., Holmen, O.L., Hveem, K., Jansson, J.H., Jockel, K.H., Kessler, T., Kriebel, J., Laugwitz, K.L., Marouli, E., Martinelli, N., McCarthy, M.I., Zuydam, N.R. van, Meisinger, C., Esko, T., Mihailov, E., Escher, S.A., Alver, M., Moebus, S., Morris, A.D., Virtamo, J., Nikpay, M., Olivieri, O., Provost, S., AlQarawi, A., Robertson, N.R., Akinsansya, K.O., Reilly, D.F., Vogt, T.F., Yin, W., Asselbergs, F.W., Kooperberg, C., Jackson, R.D., Stahl, E., Muller-Nurasyid, M., Strauch, K., Varga, T.V., Waldenberger, M., Zeng, L.Y., Chowdhury, R., Salomaa, V., Ford, I., Jukema, J.W., Amouyel, P., Kontto, J., Nordestgaard, B.G., Ferrieres, J., Saleheen, D., Sattar, N., Surendran, P., Wagner, A., Young, R., Howson, J.M.M., Butterworth, A.S., Danesh, J., Ardissino, D., Bottinger, E.P., Erbel, R., Franks, P.W., Girelli, D., Hall, A.S., Hovingh, G.K., Kastrati, A., Lieb, W., Meitinger, T., Kraus, W.E., Shah, S.H., McPherson, R., Orho-Melander, M., Melander, O., Metspalu, A., Palmer, C.N.A., Peters, A., Rader, D.J., Reilly, M.P., Loos, R.J.F., Reiner, A.P., Roden, D.M., Tardif, J.C., Thompson, J.R., Wareham, N.J., Watkins, H., Willer, C.J., Samani, N.J., Schunkert, H., Deloukas, P., Kathiresan, S., Wellcome Trust Case Control, MORGAM Investigators, and Myocardial Infarction Genetics
- Subjects
expression quantitative trait loci ,single nucleotide polymorphism ,cholesteryl ester transfer protein ,genome-wide association ,genetics - Abstract
BACKGROUND: Genome-wide association studies have so far identified 56 loci associated with risk of coronary artery disease (CAD). Many CAD loci show pleiotropy; that is, they are also associated with other diseases or traits. OBJECTIVES: This study sought to systematically test if genetic variants identified for non-CAD diseases/traits also associate with CAD and to undertake a comprehensive analysis of the extent of pleiotropy of all CAD loci. METHODS: In discovery analyses involving 42,335 CAD cases and 78,240 control subjects we tested the association of 29,383 common (minor allele frequency >5%) single nucleotide polymorphisms available on the exome array, which included a substantial proportion of known or suspected single nucleotide polymorphisms associated with common diseases or traits as of 2011. Suggestive association signals were replicated in an additional 30,533 cases and 42,530 control subjects. To evaluate pleiotropy, we tested CAD loci for association with cardiovascular risk factors (lipid traits, blood pressure phenotypes, body mass index, diabetes, and smoking behavior), as well as with other diseases/traits through interrogation of currently available genome-wide association study catalogs. RESULTS: We identified 6 new loci associated with CAD at genome-wide significance: on 2q37 (KCNJ13-GIGYF2), 6p21 (C2), 11p15 (MRVI1-CTR9), 12q13 (LRP1), 12q24 (SCARB1), and 16q13 (CETP). Risk allele frequencies ranged from 0.15 to 0.86, and odds ratio per copy of the risk allele ranged from 1.04 to 1.09. Of 62 new and known CAD loci, 24 (38.7%) showed statistical association with a traditional cardiovascular risk factor, with some showing multiple associations, and 29 (47%) showed associations at p < 1 × 10(-4) with a range of other diseases/traits. CONCLUSIONS: We identified 6 loci associated with CAD at genome-wide significance. Several CAD loci show substantial pleiotropy, which may help us understand the mechanisms by which these loci affect CAD risk.
- Published
- 2017
7. China’s core executive Leadership styles, structures and processes under Xi Jinping
- Author
-
Heilmann, S., Stepan, M., Political Science and Public Administration, and Multi-layered governance in EUrope and beyond (MLG)
- Subjects
SDG 16 - Peace, Justice and Strong Institutions - Abstract
Since Xi Jinping took the reins of the Chinese Communist Party and as President of the People’s Republic of China, the country’s domestic and foreign politics have undergone considerable changes. China has become more assertive as an international actor. It has launched new diplomatic initiatives centring on large infrastructure projects, while at the same time contributing to tense relations with many of its neighbouring countries. At home, several pieces of security-related legislation have further constrained the activities of both domestic as well as foreign civil actors. Participating scholars’ expertise covers a wide variety of issue areas, ranging from economic policy making to cyberspace politics, and from societal control to military modernization. MERICS Paper on China No. 1 - “China’s core executive: leadership styles, structures and processes under Xi Jinping” is an essay collection which offers the most comprehensive, authoritative and up-to-date account of the changes to China’s core executive under Xi Jinping through its analysis of developments in different policy areas. One observation is dominant – China has moved in further in the direction of top-down, autocratic policy making. The authors – among them renowned experts such as Roderick Mac Farquhar, Barry Naughton, Joseph Fewsmith, You Ji, Victor Shih, and Anthony Saich – discuss the effects of this on current policymaking and policy outcomes, as well as offering a thought-provoking look into the future. What happens if Xi Jinping fails with his overall reform agenda? What if he succeeds in strengthening the control of the party and in restructuring the Chinese economy? Will China’s IT-backed authoritarianism act as a model and spread to other countries, challenging Western democratic modes of governance? Whatever the future holds, such developments will have implications not only for China, but for all its close economic and political partners.
- Published
- 2016
8. Top-level design and local-level paralysis: Local politics in times of political centralisation
- Author
-
Stepan, M., Ahlers, A.L., Heilmann, S., Political Science and Public Administration, and Multi-layered governance in EUrope and beyond (MLG)
- Subjects
SDG 16 - Peace, Justice and Strong Institutions - Abstract
China’s leadership under Xi has reinforced the party’s hierarchical command structures, demonstrated through its top-down campaigns, focusing on austerity, anti-corruption efforts and party discipline. It has reinvigorated sanctioning and incentive mechanisms for local cadres, with unknown effects on their long-term performance and loyalty to the CCP. Re-centralising the intergovernmental financial system strengthens the overall steering capacity of the central government temporarily, but does not alleviate the fiscal stress on local governments. The central government is pushing for greater market orientation at the local level, resulting, thus far, in short-sighted solutions that will end up reducing transparency concerning local debt. Local leaders are abstaining from bold policy moves out of fear of demotion, exclusion from the party, or legal repercussions. Consequently, subnational governments have ceased to act as independent actors of policy initiative and innovation. Policy piloting and experimentation will remain an important component of the policy process, but will be employed only very selectively and under the auspices of the central government. These reconfigurations of central-local relations give the central leadership more tools to enforce local compliance, and they appear to be effective in the short term. But they will suffocate subnational policy initiative, ultimately undermining the adaptive capacity of the Chinese state.
- Published
- 2016
9. Genome-wide association study identifies multiple susceptibility loci for glioma
- Author
-
Kinnersley, B, Labussière, M, Holroyd, A, Di Stefano, A-L, Broderick, P, Vijayakrishnan, J, Mokhtari, K, Delattre, J-Y, Gousias, K, Schramm, J, Schoemaker, MJ, Fleming, SJ, Herms, S, Heilmann, S, Schreiber, S, Wichmann, H-E, Nöthen, MM, Swerdlow, A, Lathrop, M, Simon, M, Bondy, M, Sanson, M, and Houlston, RS
- Abstract
Previous genome-wide association studies (GWASs) have shown that common genetic variation contributes to the heritable risk of glioma. To identify new glioma susceptibility loci, we conducted a meta-analysis of four GWAS (totalling 4,147 cases and 7,435 controls), with imputation using 1000 Genomes and UK10K Project data as reference. After genotyping an additional 1,490 cases and 1,723 controls we identify new risk loci for glioblastoma (GBM) at 12q23.33 (rs3851634, near POLR3B, P=3.02 × 10−9) and non-GBM at 10q25.2 (rs11196067, near VTI1A, P=4.32 × 10−8), 11q23.2 (rs648044, near ZBTB16, P=6.26 × 10−11), 12q21.2 (rs12230172, P=7.53 × 10−11) and 15q24.2 (rs1801591, near ETFA, P=5.71 × 10−9). Our findings provide further insights into the genetic basis of the different glioma subtypes.
- Published
- 2015
10. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment
- Author
-
Lacour, A., Espinosa, A., Louwersheimer, E., Heilmann, S., Hernandez, I., Wolfsgruber, S., Fernandez, V., Wagner, H., Rosende-Roca, M., Mauleon, A., Moreno-Grau, S., Vargas, L., Pijnenburg, Y. A. L., Koene, T., Rodriguez-Gomez, O., Ortega, G., Ruiz, S., Holstege, H., Sotolongo-Grau, O., Kornhuber, J., Peters, O., Froelich, L., Huell, M., Ruether, E., Wiltfang, J., Scherer, M., Riedel-Heller, S., Alegret, M., Noethen, M. M., Scheltens, P., Wagner, M., Tarraga, L., Jessen, F., Boada, M., Maier, W., van der Flier, W. M., Becker, T., Ramirez, A., Ruiz, A., Lacour, A., Espinosa, A., Louwersheimer, E., Heilmann, S., Hernandez, I., Wolfsgruber, S., Fernandez, V., Wagner, H., Rosende-Roca, M., Mauleon, A., Moreno-Grau, S., Vargas, L., Pijnenburg, Y. A. L., Koene, T., Rodriguez-Gomez, O., Ortega, G., Ruiz, S., Holstege, H., Sotolongo-Grau, O., Kornhuber, J., Peters, O., Froelich, L., Huell, M., Ruether, E., Wiltfang, J., Scherer, M., Riedel-Heller, S., Alegret, M., Noethen, M. M., Scheltens, P., Wagner, M., Tarraga, L., Jessen, F., Boada, M., Maier, W., van der Flier, W. M., Becker, T., Ramirez, A., and Ruiz, A.
- Abstract
Few data are available concerning the role of risk markers for Alzheimer's disease (AD) in progression to AD dementia among subjects with mild cognitive impairment (MCI). We therefore investigated the role of well-known AD-associated single-nucleotide polymorphism (SNP) in the progression from MCI to AD dementia. Four independent MCI data sets were included in the analysis: (a) the German study on Aging, Cognition and Dementia in primary care patients (n = 853); (b) the German Dementia Competence Network (n = 812); (c) the Fundacio ACE from Barcelona, Spain (n = 1245); and (d) the MCI data set of the Amsterdam Dementia Cohort (n = 306). The effects of single markers and combined polygenic scores were measured using Cox proportional hazards models and meta-analyses. The clusterin (CLU) locus was an independent genetic risk factor for MCI to AD progression (CLU rs9331888: hazard ratio (HR) = 1.187 (1.054-1.32); P = 0.0035). A polygenic score (PGS1) comprising nine established genome-wide AD risk loci predicted a small effect on the risk of MCI to AD progression in APOE-e4 (apolipoprotein E-e4) carriers (HR = 1.746 (1.029-2.965); P = 0.038). The novel AD loci reported by the International Genomics of Alzheimer's Project were not implicated in MCI to AD dementia progression. SNP-based polygenic risk scores comprising currently available AD genetic markers did not predict MCI to AD progression. We conclude that SNPs in CLU are potential markers for MCI to AD progression.
- Published
- 2017
11. Formal or informal mentoring: What drives employees to seek informal mentors?
- Author
-
Holt, D, Markova, G, Dhaenens, A, Marler, L, Heilmann, S, Holt, D, Markova, G, Dhaenens, A, Marler, L, and Heilmann, S
- Published
- 2016
12. Prediction of male-pattern baldness from genotypes
- Author
-
Liu, F. (Fan), Hamer, M.A. (Merel), Heilmann, S. (Sarah), Herold, C. (Christine), Moebus, S. (Susanne), Hofman, A. (Albert), Uitterlinden, A.G. (André), Nöthen, M.M. (Markus), Duijn, C.M. (Cornelia) van, Nijsten, T.E.C. (Tamar), Kayser, M.H. (Manfred), Liu, F. (Fan), Hamer, M.A. (Merel), Heilmann, S. (Sarah), Herold, C. (Christine), Moebus, S. (Susanne), Hofman, A. (Albert), Uitterlinden, A.G. (André), Nöthen, M.M. (Markus), Duijn, C.M. (Cornelia) van, Nijsten, T.E.C. (Tamar), and Kayser, M.H. (Manfred)
- Abstract
The global demand for products that effectively prevent the development of male-pattern baldness (MPB) has drastically increased. However, there is currently no established genetic model for the estimation of MPB risk. We conducted a prediction analysis using single-nucleotide polymorphisms (SNPs) identified from previous GWASs of MPB in a total of 2725 German and Dutch males. A logistic regression model considering the genotypes of 25 SNPs from 12 genomic loci demonstrates that early-onset MPB risk is predictable at an accuracy level of 0.74 when 14 SNPs were included in the model, and measured using the area under the receiver-operating characteristic curves (AUC). Considering age as an additional predictor, the model can predict normal MPB status in middle-Aged and elderly individuals at a slightly lower accuracy (AUC 0.69-0.71) when 6-11 SNPs were used. A variance partitioning analysis suggests that 55.8% of early-onset MPB genetic liability can be explained by common autosomal SNPs and 23.3% by X-chromosome SNPs. For normal MPB status in elderly individuals, the proportion of explainable variance is lower (42.4% for autosomal and 9.8% for X-chromosome SNPs). The gap between GWAS findings and the variance partitioning results could be explained by a large body of common DNA variants with small effects that will likely be identified in GWAS of increased sample sizes. Although the accuracy obtained here has not reached a clinically desired level, our model was highly informative for up to 19% of Europeans, thus may assist decision making on early MPB intervention actions and in forensic investigations.
- Published
- 2016
- Full Text
- View/download PDF
13. Compelling evidence for FANCM as a breast cancer susceptibility gene
- Author
-
Neidhardt, G., Hauke, J., Heilmann, S., Hellebrand, H., Surowy, H. M., Klaschik, K., Honisch, E., Gehrig, A., Sutter, C., Rump, A., Bogdanova-Markov, N., Bugert, P., Mangold, E., Steinemann, D., Ramirez, A., Ditsch, N., Arnold, N., Niederacher, D., Burwinkel, B., Thiele, H., Altmueller, I., Nuernberg, P., Engel, C., Wappenschmidt, B., Rhiem, K., Meindl, A., Schmutzler, R. K., Hahnen, E., Neidhardt, G., Hauke, J., Heilmann, S., Hellebrand, H., Surowy, H. M., Klaschik, K., Honisch, E., Gehrig, A., Sutter, C., Rump, A., Bogdanova-Markov, N., Bugert, P., Mangold, E., Steinemann, D., Ramirez, A., Ditsch, N., Arnold, N., Niederacher, D., Burwinkel, B., Thiele, H., Altmueller, I., Nuernberg, P., Engel, C., Wappenschmidt, B., Rhiem, K., Meindl, A., Schmutzler, R. K., and Hahnen, E.
- Published
- 2016
14. Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment
- Author
-
Lacour, A, primary, Espinosa, A, additional, Louwersheimer, E, additional, Heilmann, S, additional, Hernández, I, additional, Wolfsgruber, S, additional, Fernández, V, additional, Wagner, H, additional, Rosende-Roca, M, additional, Mauleón, A, additional, Moreno-Grau, S, additional, Vargas, L, additional, Pijnenburg, Y A L, additional, Koene, T, additional, Rodríguez-Gómez, O, additional, Ortega, G, additional, Ruiz, S, additional, Holstege, H, additional, Sotolongo-Grau, O, additional, Kornhuber, J, additional, Peters, O, additional, Frölich, L, additional, Hüll, M, additional, Rüther, E, additional, Wiltfang, J, additional, Scherer, M, additional, Riedel-Heller, S, additional, Alegret, M, additional, Nöthen, M M, additional, Scheltens, P, additional, Wagner, M, additional, Tárraga, L, additional, Jessen, F, additional, Boada, M, additional, Maier, W, additional, van der Flier, W M, additional, Becker, T, additional, Ramirez, A, additional, and Ruiz, A, additional
- Published
- 2016
- Full Text
- View/download PDF
15. Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene
- Author
-
Ruiz, A., Heilmann, S., Harold, D., Gerrish, A., Sims, R., Sotolongo-Grau, O., Espinosa, A., Alegret, M., Arrieta, J. L., Lacour, A., Leber, M., Becker, J., Becker, T., Lafuente, A., Ruiz, S., Vargas, L., Rodríguez, O., Ortega, G., Dominguez, M-A, IGAP, Mayeux, R., Haines, J. L., Pericak-Vance, M. A., Hernández, I., Farrer, L. A., Schellenberg, G. D., Chouraki, V., Launer, L. J., van Duijn, C., Seshadri, S., Antúnez, C., Breteler, Monique, Serrano-Ríos, M., Jessen, F., Wagner, H., Tárraga, L., Nöthen, M. M., Maier, W., Boada, M., Ramírez, A., Thelen, M., Mauleón, A., Rosende-Roca, M., Bellenguez, C., Bis, J. C., Breteler, M. M., and Epidemiology
- Subjects
SNP ,thyroid receptor ,Genomics ,Locus (genetics) ,Single-nucleotide polymorphism ,Genome-wide association study ,genetics [Alzheimer Disease] ,TRIP4 protein, human ,genetics [Genetic Loci] ,Biology ,Polymorphism, Single Nucleotide ,molecular epidemiology ,Cellular and Molecular Neuroscience ,Alzheimer Disease ,dementia risk ,medicine ,GWAS ,Humans ,Genetic Predisposition to Disease ,ddc:610 ,Biological Psychiatry ,Genetics ,Odds ratio ,DNA ,genetics [Transcription Factors] ,medicine.disease ,R1 ,Psychiatry and Mental health ,Genetic Loci ,Spain ,Multiple comparisons problem ,genetics [Polymorphism, Single Nucleotide] ,Original Article ,Alzheimer's disease ,Follow-Up Studies ,Genome-Wide Association Study ,Transcription Factors - Abstract
To follow-up loci discovered by the International Genomics of Alzheimer's Disease Project, we attempted independent replication of 19 single nucleotide polymorphisms (SNPs) in a large Spanish sample (Fundacio ACE data set; 1808 patients and 2564 controls). Our results corroborate association with four SNPs located in the genes INPP5D, MEF2C, ZCWPW1 and FERMT2, respectively. Of these, ZCWPW1 was the only SNP to withstand correction for multiple testing (P = 0.000655). Furthermore, we identify TRIP4 (rs74615166) as a novel genome-wide significant locus for Alzheimer's disease risk (odds ratio = 1.31; confidence interval 95% (1.19-1.44); P = 9.74 x 10(-9)).
- Published
- 2014
- Full Text
- View/download PDF
16. Susceptibility variants on chromosome 7p21.1 suggest HDAC9 as a new candidate gene for male-pattern baldness
- Author
-
Brockschmidt, F.F., Heilmann, S., Ellis, J.A., Eigelshoven, S., Hanneken, S., Herold, C., Moebus, Susanne, Alblas, M.A., Lippke, B., Kluck, N., Priebe, L., Degenhardt, F.A., Jamra, R.A., Meesters, C., Jöckel, Karl-Heinz, Erbel, Raimund, Harrap, S., Schumacher, J., Fröhlich, H., Kruse, R., Hillmer, A.M., Becker, T., and Nöthen, M.M.
- Subjects
Adult ,Male ,Genotype ,Medizin ,Alopecia ,genetics [Chromosomes, Human, Pair 7] ,Polymorphism, Single Nucleotide ,Histone Deacetylases ,Repressor Proteins ,genetics [Histone Deacetylases] ,genetics [Repressor Proteins] ,Alternative Splicing ,Case-Control Studies ,genetics [Alternative Splicing] ,genetics [Polymorphism, Single Nucleotide] ,HDAC9 protein, human ,Humans ,Genetic Predisposition to Disease ,ddc:610 ,genetics [Genetic Predisposition to Disease] ,Chromosomes, Human, Pair 7 ,genetics [Alopecia] ,Genome-Wide Association Study - Abstract
Male-pattern baldness (androgenetic alopecia, AGA) is the most common form of hair loss among humans. Research has shown that it is caused by genetic factors. Numerous studies have unequivocally identified two major genetic risk loci for AGA: the X-chromosomal AR/EDA2R locus, and the PAX1/FOXA2 locus on chromosome 20.To identify further candidate genes for AGA, and thus gain further insights into this phenotype.A German sample of 581 severely affected cases and 617 controls was used to perform a genome-wide association study. The identified associated locus was further analysed by fine-mapping, and then independently replicated in an Australian sample. Expression and pathway analyses were performed to characterize the susceptibility gene identified.The most significant association signal was obtained for rs756853 (P = 1·64 × 10(-7) ), which is located intronically in the histone deacetylase 9 (HDAC9) gene. Fine-mapping and a family-based analysis revealed that rs756853 and the 6-kb distal rs2249817 were the most highly associated single nucleotide polymorphisms. The association finding was replicated in an independent Australian sample, when the analysis was restricted to severely affected cases and unaffected controls (P = 0·026). Analysis of rs2249817 in a combined sample of severely affected German and Australian cases and unaffected controls revealed a strong association signal (P = 9·09 × 10(-8) ). Tissue expression studies demonstrated HDAC9 expression in various tissues, including tissues of relevance to AGA. No strong genotypic effects were observed in genotype-specific expression or splice studies. Pathway analyses supported the hypothesis that HDAC9 plays a functional role in AGA via interaction with the AR gene.The present study suggests that HDAC9 is the third AGA susceptibility gene.
- Published
- 2011
- Full Text
- View/download PDF
17. Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene
- Author
-
Ruiz, A. (A.), Heilmann, S. (Sarah), Becker, T. (Tim), Hernández, I. (Isabel), Wagner, H. (Hermann), Thelen, K.M. (Karin ), Mauleón, A. (A.), Rosende-Roca, M. (M.), Bellenguez, C. (Céline), Bis, J.C. (Joshua), Harold, D. (Denise), Gerrish, A. (Amy), Sims, R. (Rebecca), Sotolongo-Grau, O. (O.), Espinosa, L. (Lluis), Alegret, M. (M.), Arrieta, J.L. (J.), Lacour, A. (A.), Leber, I. (Isabelle), Becker, J. (Jessica), Lafuente, A. (A.), Ruiz, S. (S.), Vargas, L. (L.), Rodríguez, P.M., Ortega, G. (G.), Dominguez, M.A., Mayeux, R. (Richard), Haines, J.L. (Jonathan), Pericak-Vance, M.A. (Margaret), Farrer, L.A. (Lindsay), Schellenberg, G.D. (Gerard), Chouraki, V. (Vincent), Launer, L.J. (Lenore), Duijn, C.M. (Cornelia) van, Seshadri, S. (Sudha), Antúnez, C. (C.), Breteler, M.M.B. (Monique), Serrano-Ríos, M. (Manuel), Jessen, F., Tárraga, L. (L.), Nöthen, M.M. (Markus), Maier, W. (Wolfgang), Boada, M. (Mercè), Ramírez, M.J. (María), Ruiz, A. (A.), Heilmann, S. (Sarah), Becker, T. (Tim), Hernández, I. (Isabel), Wagner, H. (Hermann), Thelen, K.M. (Karin ), Mauleón, A. (A.), Rosende-Roca, M. (M.), Bellenguez, C. (Céline), Bis, J.C. (Joshua), Harold, D. (Denise), Gerrish, A. (Amy), Sims, R. (Rebecca), Sotolongo-Grau, O. (O.), Espinosa, L. (Lluis), Alegret, M. (M.), Arrieta, J.L. (J.), Lacour, A. (A.), Leber, I. (Isabelle), Becker, J. (Jessica), Lafuente, A. (A.), Ruiz, S. (S.), Vargas, L. (L.), Rodríguez, P.M., Ortega, G. (G.), Dominguez, M.A., Mayeux, R. (Richard), Haines, J.L. (Jonathan), Pericak-Vance, M.A. (Margaret), Farrer, L.A. (Lindsay), Schellenberg, G.D. (Gerard), Chouraki, V. (Vincent), Launer, L.J. (Lenore), Duijn, C.M. (Cornelia) van, Seshadri, S. (Sudha), Antúnez, C. (C.), Breteler, M.M.B. (Monique), Serrano-Ríos, M. (Manuel), Jessen, F., Tárraga, L. (L.), Nöthen, M.M. (Markus), Maier, W. (Wolfgang), Boada, M. (Mercè), and Ramírez, M.J. (María)
- Abstract
To follow-up loci discovered by the International Genomics of Alzheimer's Disease Project, we attempted independent replication of 19 single nucleotide polymorphisms (SNPs) in a large Spanish sample (Fundació ACE data set; 1808 patients and 2564 controls). Our results corroborate association with four SNPs located in the genes INPP5D, MEF2C, ZCWPW1 and FERMT2, respectively. Of these, ZCWPW1 was the only SNP to withstand correction for multiple testing (P=0.000655). Furthermore, we identify TRIP4 (rs74615166) as a novel genome-wide significant locus for Alzheimer's disease risk (odds ratio=1.31; confidence interval 95% (1.19-1.44); P=9.74 × 10 - 9).
- Published
- 2014
- Full Text
- View/download PDF
18. Microdeletions including FMR1 in three female patients with intellectual disability - further delineation of the phenotype and expression studies
- Author
-
Zink, A M, Wohlleber, E, Engels, H, Rødningen, O K, Ravn, K, Heilmann, S, Rehnitz, J, Katzorke, N, Kraus, C, Blichfeldt, S, Hoffmann, P, Reutter, H, Brockschmidt, F F, Kreiß-Nachtsheim, M, Vogt, P H, Prescott, T E, Tümer, Z, Lee, J A, Zink, A M, Wohlleber, E, Engels, H, Rødningen, O K, Ravn, K, Heilmann, S, Rehnitz, J, Katzorke, N, Kraus, C, Blichfeldt, S, Hoffmann, P, Reutter, H, Brockschmidt, F F, Kreiß-Nachtsheim, M, Vogt, P H, Prescott, T E, Tümer, Z, and Lee, J A
- Abstract
Fragile X syndrome (FXS) is one of the most common causes of intellectual disability/developmental delay (ID/DD), especially in males. It is caused most often by CGG trinucleotide repeat expansions, and less frequently by point mutations and partial or full deletions of the FMR1 gene. The wide clinical spectrum of affected females partly depends on their X-inactivation status. Only few female ID/DD patients with microdeletions including FMR1 have been reported. We describe 3 female patients with 3.5-, 4.2- and 9.2-Mb de novo microdeletions in Xq27.3-q28 containing FMR1. X-inactivation was random in all patients, yet they presented with ID/DD as well as speech delay, macrocephaly and other features attributable to FXS. No signs of autism were present. Here, we further delineate the clinical spectrum of female patients with microdeletions. FMR1 expression studies gave no evidence for an absolute threshold below which signs of FXS present. Since FMR1 expression is known to be highly variable between unrelated females, and since FMR1 mRNA levels have been suggested to be more similar among family members, we further explored the possibility of an intrafamilial effect. Interestingly, FMR1 mRNA levels in all 3 patients were significantly lower than in their respective mothers, which was shown to be specific for patients with microdeletions containing FMR1.
- Published
- 2014
19. Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene
- Author
-
Ruiz, A, Heilmann, S, Becker, T, Hernandez, I, Wagner, H, Thelen, M, Mauleon, A, Rosende-Roca, M, Bellenguez, C, Bis, JC, Harold, D, Gerrish, A, Sims, R, Sotolongo-Grau, O, Espinosa, A, Alegret, M, Arrieta, JL, Lacour, A, Leber, M, Becker, J, Lafuente, A, Ruiz, S, Vargas, L, Rodriguez, O, Ortega, G, Dominguez, MA, Mayeux, R, Haines, JL, Pericak-Vance, MA, Farrer, LA, Schellenberg, GD, Chouraki, V, Launer, LJ (Lenore), Duijn, Cornelia, Seshadri, S, Antunez, C, Breteler, Monique, Serrano-Rios, M, Jessen, F, Tarraga, L, Nothen, MM, Maier, W, Boada, M, Ramirez, A, Ruiz, A, Heilmann, S, Becker, T, Hernandez, I, Wagner, H, Thelen, M, Mauleon, A, Rosende-Roca, M, Bellenguez, C, Bis, JC, Harold, D, Gerrish, A, Sims, R, Sotolongo-Grau, O, Espinosa, A, Alegret, M, Arrieta, JL, Lacour, A, Leber, M, Becker, J, Lafuente, A, Ruiz, S, Vargas, L, Rodriguez, O, Ortega, G, Dominguez, MA, Mayeux, R, Haines, JL, Pericak-Vance, MA, Farrer, LA, Schellenberg, GD, Chouraki, V, Launer, LJ (Lenore), Duijn, Cornelia, Seshadri, S, Antunez, C, Breteler, Monique, Serrano-Rios, M, Jessen, F, Tarraga, L, Nothen, MM, Maier, W, Boada, M, and Ramirez, A
- Abstract
To follow-up loci discovered by the International Genomics of Alzheimer's Disease Project, we attempted independent replication of 19 single nucleotide polymorphisms (SNPs) in a large Spanish sample (Fundacio ACE data set; 1808 patients and 2564 controls). Our results corroborate association with four SNPs located in the genes INPP5D, MEF2C, ZCWPW1 and FERMT2, respectively. Of these, ZCWPW1 was the only SNP to withstand correction for multiple testing (P = 0.000655). Furthermore, we identify TRIP4 (rs74615166) as a novel genome-wide significant locus for Alzheimer's disease risk (odds ratio = 1.31; confidence interval 95% (1.19-1.44); P = 9.74 x 10(-9)).
- Published
- 2014
20. Androgenetic Alopecia: Identification of Four Genetic Risk Loci and Evidence for the Contribution of WNT Signaling to Its Etiology
- Author
-
Heilmann, S., Kiefer, A.K., Fricker, N., Drichel, D., Hillmer, A.M., Herold, C., Tung, J.Y., Eriksson, N., Redler, S., Betz, R.C., Li, R., Karason, A., Nyholt, D.R., Song, K., Vermeulen, S., Kanoni, S., Dedoussis, G., Martin, N.G., Kiemeney, L.A.L.M., Mooser, V., Stefansson, K., Richards, J.B., Becker, T., Brockschmidt, F.F., Hinds, D.A., Nothen, M.M., Heilmann, S., Kiefer, A.K., Fricker, N., Drichel, D., Hillmer, A.M., Herold, C., Tung, J.Y., Eriksson, N., Redler, S., Betz, R.C., Li, R., Karason, A., Nyholt, D.R., Song, K., Vermeulen, S., Kanoni, S., Dedoussis, G., Martin, N.G., Kiemeney, L.A.L.M., Mooser, V., Stefansson, K., Richards, J.B., Becker, T., Brockschmidt, F.F., Hinds, D.A., and Nothen, M.M.
- Abstract
Item does not contain fulltext, The pathogenesis of androgenetic alopecia (AGA, male-pattern baldness) is driven by androgens, and genetic predisposition is the major prerequisite. Candidate gene and genome-wide association studies have reported that single-nucleotide polymorphisms (SNPs) at eight different genomic loci are associated with AGA development. However, a significant fraction of the overall heritable risk still awaits identification. Furthermore, the understanding of the pathophysiology of AGA is incomplete, and each newly associated locus may provide novel insights into contributing biological pathways. The aim of this study was to identify unknown AGA risk loci by replicating SNPs at the 12 genomic loci that showed suggestive association (5 x 10(-8)
- Published
- 2013
21. No genetic support for a contribution of prostaglandins to the aetiology of androgenetic alopecia
- Author
-
Heilmann, S., Nyholt, D.R., Brockschmidt, F.F., Hillmer, A.M., Herold, C., Maan, C., Becker, T., Martin, N.G., Nothen, M.M., Kiemeney, L.A.L.M., Vermeulen, S., et al., Heilmann, S., Nyholt, D.R., Brockschmidt, F.F., Hillmer, A.M., Herold, C., Maan, C., Becker, T., Martin, N.G., Nothen, M.M., Kiemeney, L.A.L.M., Vermeulen, S., and et al.
- Abstract
Item does not contain fulltext
- Published
- 2013
22. Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases
- Author
-
Li, R., Brockschmidt, F.F., Kiefer, A.K., Stefansson, H., Nyholt, D.R., Song, K., Vermeulen, S., Kanoni, S., Glass, D., Medland, S.E., Dimitriou, M., Waterworth, D., Tung, J.Y., Geller, F., Heilmann, S., Hillmer, A.M., Bataille, V., Eigelshoven, S., Hanneken, S., Moebus, S., Herold, C., Heijer, M. den, Montgomery, G.W., Deloukas, P., Eriksson, N., Heath, A.C., Becker, T., Sulem, P., Mangino, M., Vollenweider, P., Spector, T.D., Dedoussis, G., Martin, N.G., Kiemeney, L.A., Mooser, V., Stefansson, K., Hinds, D.A., Nothen, Markus, Richards, J.B., Li, R., Brockschmidt, F.F., Kiefer, A.K., Stefansson, H., Nyholt, D.R., Song, K., Vermeulen, S., Kanoni, S., Glass, D., Medland, S.E., Dimitriou, M., Waterworth, D., Tung, J.Y., Geller, F., Heilmann, S., Hillmer, A.M., Bataille, V., Eigelshoven, S., Hanneken, S., Moebus, S., Herold, C., Heijer, M. den, Montgomery, G.W., Deloukas, P., Eriksson, N., Heath, A.C., Becker, T., Sulem, P., Mangino, M., Vollenweider, P., Spector, T.D., Dedoussis, G., Martin, N.G., Kiemeney, L.A., Mooser, V., Stefansson, K., Hinds, D.A., Nothen, Markus, and Richards, J.B.
- Abstract
Contains fulltext : 109543.pdf (publisher's version ) (Open Access), Androgenetic alopecia (AGA) is a highly heritable condition and the most common form of hair loss in humans. Susceptibility loci have been described on the X chromosome and chromosome 20, but these loci explain a minority of its heritable variance. We conducted a large-scale meta-analysis of seven genome-wide association studies for early-onset AGA in 12,806 individuals of European ancestry. While replicating the two AGA loci on the X chromosome and chromosome 20, six novel susceptibility loci reached genome-wide significance (p = 2.62x10(-)(9)-1.01x10(-)(1)(2)). Unexpectedly, we identified a risk allele at 17q21.31 that was recently associated with Parkinson's disease (PD) at a genome-wide significant level. We then tested the association between early-onset AGA and the risk of PD in a cross-sectional analysis of 568 PD cases and 7,664 controls. Early-onset AGA cases had significantly increased odds of subsequent PD (OR = 1.28, 95% confidence interval: 1.06-1.55, p = 8.9x10(-)(3)). Further, the AGA susceptibility alleles at the 17q21.31 locus are on the H1 haplotype, which is under negative selection in Europeans and has been linked to decreased fertility. Combining the risk alleles of six novel and two established susceptibility loci, we created a genotype risk score and tested its association with AGA in an additional sample. Individuals in the highest risk quartile of a genotype score had an approximately six-fold increased risk of early-onset AGA [odds ratio (OR) = 5.78, p = 1.4x10(-)(8)(8)]. Our results highlight unexpected associations between early-onset AGA, Parkinson's disease, and decreased fertility, providing important insights into the pathophysiology of these conditions.
- Published
- 2012
23. Microdeletions Including FMR1 in Three Female Patients with Intellectual Disability - Further Delineation of the Phenotype and Expression Studies
- Author
-
Zink, A.M., primary, Wohlleber, E., additional, Engels, H., additional, Rødningen, O.K., additional, Ravn, K., additional, Heilmann, S., additional, Rehnitz, J., additional, Katzorke, N., additional, Kraus, C., additional, Blichfeldt, S., additional, Hoffmann, P., additional, Reutter, H., additional, Brockschmidt, F.F., additional, Kreiß-Nachtsheim, M., additional, Vogt, P.H., additional, Prescott, T.E., additional, Tümer, Z., additional, and Lee, J.A., additional
- Published
- 2014
- Full Text
- View/download PDF
24. Systematic evaluation of pleiotropy identifies 6 further loci associated with coronary artery disease
- Author
-
Webb, T, Erdmann, J, Stirrups, K, Stitziel, N, Masca, N, Jansen, H, Kanoni, S, Nelson, C, Ferrario, P, König, I, Eicher, J, Johnson, A, Hamby, S, Betsholtz, C, Ruusalepp, A, Franzén, O, Schadt, E, Björkegren, J, Weeke, P, Auer, P, Schick, U, Lu, Y, Zhang, H, Dube, M, Goel, A, Farrall, M, Peloso, G, Won, H, Do, R, van Iperen, E, Kruppa, J, Mahajan, A, Scott, R, Willenborg, C, Braund, P, van Capelleveen, J, Doney, A, Donnelly, L, Asselta, R, Merlini, P, Duga, S, Marziliano, N, Denny, J, Shaffer, C, El-Mokhtari, N, Franke, A, Heilmann, S, Hengstenberg, C, Hoffmann, P, Holmen, O, Hveem, K, Jansson, J, Jöckel, K, Kessler, T, Kriebel, J, Laugwitz, K, Marouli, E, Martinelli, N, McCarthy, M, Van Zuydam, N, Meisinger, C, Esko, T, Mihailov, E, Escher, S, Alver, M, Moebus, S, Morris, A, Virtamo, J, Nikpay, M, Olivieri, O, Provost, S, AlQarawi, A, Robertson, N, Akinsansya, K, Reilly, D, Vogt, T, Yin, W, Asselbergs, F, Kooperberg, C, Jackson, R, Stahl, E, Müller-Nurasyid, M, Strauch, K, Varga, T, Waldenberger, M, Consortium, Wellcome Trust Case Control, Zeng, L, Chowdhury, R, Salomaa, V, Ford, I, Jukema, J, Amouyel, P, Kontto, J, Investigators, MORGAM, Nordestgaard, B, Ferrières, J, Saleheen, D, Sattar, N, Surendran, P, Wagner, A, Young, R, Howson, J, Butterworth, A, Danesh, J, Ardissino, D, Bottinger, E, Erbel, R, Franks, P, Girelli, D, Hall, A, Hovingh, G, Kastrati, A, Lieb, W, Meitinger, T, Kraus, W, Shah, S, McPherson, R, Orho-Melander, M, Melander, O, Metspalu, A, Palmer, C, Peters, A, Rader, D, Reilly, M, Loos, R, Reiner, A, Roden, D, Tardif, J, Thompson, J, Wareham, N, Watkins, H, Willer, C, Samani, N, Schunkert, H, Deloukas, P, Kathiresan, S, Investigators, Myocardial Infarction Genetics and CARDIoGRAM Exome Consortia, Johnson, Kathleen [0000-0002-6823-3252], Chowdhury, Rajiv [0000-0003-4881-5690], Surendran, Praveen [0000-0002-4911-6077], Howson, Joanna [0000-0001-7618-0050], Butterworth, Adam [0000-0002-6915-9015], Danesh, John [0000-0003-1158-6791], Wareham, Nicholas [0000-0003-1422-2993], and Apollo - University of Cambridge Repository
- Subjects
expression quantitative trait loci ,single nucleotide polymorphism ,cholesteryl ester transfer protein ,genome-wide association ,genetics - Abstract
BACKGROUND: Genome-wide association studies have so far identified 56 loci associated with risk of coronary artery disease (CAD). Many CAD loci show pleiotropy; that is, they are also associated with other diseases or traits. OBJECTIVES: This study sought to systematically test if genetic variants identified for non-CAD diseases/traits also associate with CAD and to undertake a comprehensive analysis of the extent of pleiotropy of all CAD loci. METHODS: In discovery analyses involving 42,335 CAD cases and 78,240 control subjects we tested the association of 29,383 common (minor allele frequency >5%) single nucleotide polymorphisms available on the exome array, which included a substantial proportion of known or suspected single nucleotide polymorphisms associated with common diseases or traits as of 2011. Suggestive association signals were replicated in an additional 30,533 cases and 42,530 control subjects. To evaluate pleiotropy, we tested CAD loci for association with cardiovascular risk factors (lipid traits, blood pressure phenotypes, body mass index, diabetes, and smoking behavior), as well as with other diseases/traits through interrogation of currently available genome-wide association study catalogs. RESULTS: We identified 6 new loci associated with CAD at genome-wide significance: on 2q37 (KCNJ13-GIGYF2), 6p21 (C2), 11p15 (MRVI1-CTR9), 12q13 (LRP1), 12q24 (SCARB1), and 16q13 (CETP). Risk allele frequencies ranged from 0.15 to 0.86, and odds ratio per copy of the risk allele ranged from 1.04 to 1.09. Of 62 new and known CAD loci, 24 (38.7%) showed statistical association with a traditional cardiovascular risk factor, with some showing multiple associations, and 29 (47%) showed associations at p < 1 × 10(-4) with a range of other diseases/traits. CONCLUSIONS: We identified 6 loci associated with CAD at genome-wide significance. Several CAD loci show substantial pleiotropy, which may help us understand the mechanisms by which these loci affect CAD risk.
25. Meta-analysis of genome-wide association studies in alopecia areata resolves HLA associations and reveals two new susceptibility loci
- Author
-
Redler, S., Petukhova, L., Ripke, S., Huang, H., Menelaou, A., Becker, T., Heilmann, S., Yamany, T., Duvic, M., Hordinsky, M., Norris, D., Price, V., Mackay-Wiggan, J., Jong, A., Destefano, G., Moebus, S., Boehm, M., Blume-Peytavi, U., Wolff, H., Lutz, G., Kruse, R., Bian, L., Amos, C., Lee, A., Gregersen, P., Bettina Blaumeiser, Altshuler, D., Clynes, R., Bakker, P. I., Noethen, M. M., Daly, M. J., Christiano, A. M., and Betz, R. C.
- Subjects
Medizin
26. A genome-wide association study with tissue transcriptomics identifies genetic drivers for classic bladder exstrophy.
- Author
-
Mingardo E, Beaman G, Grote P, Nordenskjöld A, Newman W, Woolf AS, Eckstein M, Hilger AC, Dworschak GC, Rösch W, Ebert AK, Stein R, Brusco A, Di Grazia M, Tamer A, Torres FM, Hernandez JL, Erben P, Maj C, Olmos JM, Riancho JA, Valero C, Hostettler IC, Houlden H, Werring DJ, Schumacher J, Gehlen J, Giel AS, Buerfent BC, Arkani S, Åkesson E, Rotstein E, Ludwig M, Holmdahl G, Giorgio E, Berettini A, Keene D, Cervellione RM, Younsi N, Ortlieb M, Oswald J, Haid B, Promm M, Neissner C, Hirsch K, Stehr M, Schäfer FM, Schmiedeke E, Boemers TM, van Rooij IALM, Feitz WFJ, Marcelis CLM, Lacher M, Nelson J, Ure B, Fortmann C, Gale DP, Chan MMY, Ludwig KU, Nöthen MM, Heilmann S, Zwink N, Jenetzky E, Odermatt B, Knapp M, and Reutter H
- Subjects
- Humans, Animals, Mice, Genome-Wide Association Study, Transcriptome, Ephrin-A1 genetics, Bladder Exstrophy genetics, Bladder Exstrophy complications, Urinary Bladder Neoplasms genetics
- Abstract
Classic bladder exstrophy represents the most severe end of all human congenital anomalies of the kidney and urinary tract and is associated with bladder cancer susceptibility. Previous genetic studies identified one locus to be involved in classic bladder exstrophy, but were limited to a restrict number of cohort. Here we show the largest classic bladder exstrophy genome-wide association analysis to date where we identify eight genome-wide significant loci, seven of which are novel. In these regions reside ten coding and four non-coding genes. Among the coding genes is EFNA1, strongly expressed in mouse embryonic genital tubercle, urethra, and primitive bladder. Re-sequence of EFNA1 in the investigated classic bladder exstrophy cohort of our study displays an enrichment of rare protein altering variants. We show that all coding genes are expressed and/or significantly regulated in both mouse and human embryonic developmental bladder stages. Furthermore, nine of the coding genes residing in the regions of genome-wide significance are differentially expressed in bladder cancers. Our data suggest genetic drivers for classic bladder exstrophy, as well as a possible role for these drivers to relevant bladder cancer susceptibility., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
27. Genome-wide association study in patients with posterior urethral valves.
- Author
-
van der Zanden LFM, Maj C, Borisov O, van Rooij IALM, Quaedackers JSLT, Steffens M, Schierbaum L, Schneider S, Waffenschmidt L, Kiemeney LALM, de Wall LLL, Heilmann S, Hofmann A, Gehlen J, Schumacher J, Szczepanska M, Taranta-Janusz K, Kroll P, Krzemien G, Szmigielska A, Schreuder MF, Weber S, Zaniew M, Roeleveld N, Reutter H, Feitz WFJ, and Hilger AC
- Abstract
Congenital lower urinary tract obstructions (LUTO) are most often caused by posterior urethral valves (PUV), a male limited anatomical obstruction of the urethra affecting 1 in 4,000 male live births. Little is known about the genetic background of PUV. Here, we report the largest genome-wide association study (GWAS) for PUV in 4 cohorts of patients and controls. The final meta-analysis included 756 patients and 4,823 ethnicity matched controls and comprised 5,754,208 variants that were genotyped or imputed and passed quality control in all 4 cohorts. No genome-wide significant locus was identified, but 33 variants showed suggestive significance ( P < 1 × 10
-5 ). When considering only loci with multiple variants residing within < 10 kB of each other showing suggestive significance and with the same effect direction in all 4 cohorts, 3 loci comprising a total of 9 variants remained. These loci resided on chromosomes 13, 16, and 20. The present GWAS and meta-analysis is the largest genetic study on PUV performed to date. The fact that no genome-wide significant locus was identified, can be explained by lack of power or may indicate that common variants do not play a major role in the etiology of PUV. Nevertheless, future studies are warranted to replicate and validate the 3 loci that yielded suggestive associations., Competing Interests: Author SH was employed by Life&Brain GmbH. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 van der Zanden, Maj, Borisov, van Rooij, Quaedackers, Steffens, Schierbaum, Schneider, Waffenschmidt, Kiemeney, de Wall, Heilmann, Hofmann, Gehlen, Schumacher, Szczepanska, Taranta-Janusz, Kroll, Krzemien, Szmigielska, Schreuder, Weber, Zaniew, Roeleveld, Reutter, Feitz and Hilger.)- Published
- 2022
- Full Text
- View/download PDF
28. Cooperation between melanoma cell states promotes metastasis through heterotypic cluster formation.
- Author
-
Campbell NR, Rao A, Hunter MV, Sznurkowska MK, Briker L, Zhang M, Baron M, Heilmann S, Deforet M, Kenny C, Ferretti LP, Huang TH, Perlee S, Garg M, Nsengimana J, Saini M, Montal E, Tagore M, Newton-Bishop J, Middleton MR, Corrie P, Adams DJ, Rabbie R, Aceto N, Levesque MP, Cornell RA, Yanai I, Xavier JB, and White RM
- Subjects
- Animals, Gene Expression Regulation, Neoplastic physiology, Melanoma pathology, Neural Crest pathology, Zebrafish, Cluster Analysis, Melanoma metabolism, Neoplasm Metastasis pathology, Neoplastic Cells, Circulating pathology
- Abstract
Melanomas can have multiple coexisting cell states, including proliferative (PRO) versus invasive (INV) subpopulations that represent a "go or grow" trade-off; however, how these populations interact is poorly understood. Using a combination of zebrafish modeling and analysis of patient samples, we show that INV and PRO cells form spatially structured heterotypic clusters and cooperate in the seeding of metastasis, maintaining cell state heterogeneity. INV cells adhere tightly to each other and form clusters with a rim of PRO cells. Intravital imaging demonstrated cooperation in which INV cells facilitate dissemination of less metastatic PRO cells. We identified the TFAP2 neural crest transcription factor as a master regulator of clustering and PRO/INV states. Isolation of clusters from patients with metastatic melanoma revealed a subset with heterotypic PRO-INV clusters. Our data suggest a framework for the co-existence of these two divergent cell populations, in which heterotypic clusters promote metastasis via cell-cell cooperation., Competing Interests: Declaration of interests M.R.M. receives research funding from GRAIL. D.J.A. is a paid consultant for Microbiotica and receives researching funding from Astra Zeneca and OpenTargets. M.P.L. receives research funding from Roche and Novartis. N.A. is a paid consultant for companies with an interest in liquid biopsy. R.M.W. is a paid consultant to N-of-One Therapeutics, a subsidiary of Qiagen. R.M.W. is on the Scientific Advisory Board of Consano but receives no income for this. R.M.W. receives royalty payments for the use of the casper line from Carolina Biologicals., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
29. Quantifying spatial position in a branched structure in immunostained mouse tissue sections.
- Author
-
Heilmann S, Semb H, and Nyeng P
- Subjects
- Animals, Embryo, Mammalian chemistry, Embryo, Mammalian cytology, Female, Kidney cytology, Lung cytology, Male, Mice, Pancreas cytology, Image Processing, Computer-Assisted methods, Immunohistochemistry methods, Microscopy methods
- Abstract
We have developed a protocol to quantify the position of a cell in a branched structure based on two-dimensional microscopy images of tissue sections. Biological branched structures include organs such as the lungs, kidneys, and pancreas. In these organs, cell fate has been correlated with position, based on a qualitative estimate. However, a quantitative means of evaluating the cell position has been lacking. With this protocol, the correlation between cell fate and cell position was measured in mouse embryonic pancreas. For complete details on the use and execution of this protocol, please refer to Nyeng et al. (2019)., Competing Interests: The authors declare no competing interests., (© 2021 The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
30. p120ctn-Mediated Organ Patterning Precedes and Determines Pancreatic Progenitor Fate.
- Author
-
Nyeng P, Heilmann S, Löf-Öhlin ZM, Pettersson NF, Hermann FM, Reynolds AB, and Semb H
- Subjects
- Animals, Cadherins genetics, Cell Differentiation genetics, Cell Lineage genetics, Cell Movement genetics, Embryonic Development genetics, Flow Cytometry, Gene Expression Regulation, Developmental, Humans, Islets of Langerhans growth & development, Islets of Langerhans metabolism, Mice, Pancreas metabolism, Receptors, Notch genetics, Signal Transduction genetics, Stem Cells metabolism, Delta Catenin, Body Patterning genetics, Catenins genetics, Pancreas growth & development, Pancreatic Ducts growth & development
- Abstract
The mechanism of how organ shape emerges and specifies cell fate is not understood. Pancreatic duct and endocrine lineages arise in a spatially distinct domain from the acinar lineage. Whether these lineages are pre-determined or settle once these niches have been established remains unknown. Here, we reconcile these two apparently opposing models, demonstrating that pancreatic progenitors re-localize to establish the niche that will determine their ultimate fate. We identify a p120ctn-regulated mechanism for coordination of organ architecture and cellular fate mediated by differential E-cadherin based cell sorting. Reduced p120ctn expression is necessary and sufficient to re-localize a subset of progenitors to the peripheral tip domain, where they acquire an acinar fate. The same mechanism is used re-iteratively during endocrine specification, where it balances the choice between the alpha and beta cell fates. In conclusion, organ patterning is regulated by p120ctn-mediated cellular positioning, which precedes and determines pancreatic progenitor fate., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
31. The effectiveness of the Inspiring Futures parenting programme in improving behavioural and emotional outcomes in primary school children with behavioural or emotional difficulties: study protocol for a randomised controlled trial.
- Author
-
Axford N, Warner G, Hobbs T, Heilmann S, Raja A, Berry V, Ukoumunne OC, Matthews J, Eames T, Kallitsoglou A, Blower S, Wilkinson T, Timmons L, and Bjornstad G
- Subjects
- Child, Child Development, Child, Preschool, Clinical Protocols, Emotions, Female, Humans, Male, Mental Disorders, Outcome Assessment, Health Care, Parents psychology, Schools, Affective Symptoms therapy, Child Behavior Disorders therapy, Education, Nonprofessional, Parenting psychology, Psychotherapy, Group methods
- Abstract
Background: There is a need to build the evidence base of early interventions promoting children's health and development in the UK. Malachi Specialist Family Support Services ('Malachi') is a voluntary sector organisation based in the UK that delivers a therapeutic parenting group programme called Inspiring Futures to parents of children identified as having behavioural and emotional difficulties. The programme comprises two parts, delivered sequentially: (1) a group-based programme for all parents for 10-12 weeks, and (2) one-to-one sessions with selected parents from the group-based element for up to 12 weeks., Methods/design: A randomised controlled trial will be conducted to evaluate Malachi's Inspiring Futures parenting programme. Participants will be allocated to one of two possible arms, with follow-up measures at 16 weeks (post-parent group programme) and at 32 weeks (post-one-to-one sessions with selected parents). The sample size is 248 participants with a randomisation allocation ratio of 1:1. The intervention arm will be offered the Inspiring Futures programme. The control group will receive services as usual. The aim is to determine the effectiveness of the Inspiring Futures programme on the primary outcome of behavioural and emotional difficulties of primary school children identified as having behavioural or emotional difficulties., Discussion: This study will further enhance the evidence for early intervention parenting programmes for child behavioural and emotional problems in the UK., Trial Registration: Current Controlled Trials ISRCTN32083735 . Retrospectively registered 28 October 2014.
- Published
- 2018
- Full Text
- View/download PDF
32. Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease.
- Author
-
Webb TR, Erdmann J, Stirrups KE, Stitziel NO, Masca NG, Jansen H, Kanoni S, Nelson CP, Ferrario PG, König IR, Eicher JD, Johnson AD, Hamby SE, Betsholtz C, Ruusalepp A, Franzén O, Schadt EE, Björkegren JL, Weeke PE, Auer PL, Schick UM, Lu Y, Zhang H, Dube MP, Goel A, Farrall M, Peloso GM, Won HH, Do R, van Iperen E, Kruppa J, Mahajan A, Scott RA, Willenborg C, Braund PS, van Capelleveen JC, Doney AS, Donnelly LA, Asselta R, Merlini PA, Duga S, Marziliano N, Denny JC, Shaffer C, El-Mokhtari NE, Franke A, Heilmann S, Hengstenberg C, Hoffmann P, Holmen OL, Hveem K, Jansson JH, Jöckel KH, Kessler T, Kriebel J, Laugwitz KL, Marouli E, Martinelli N, McCarthy MI, Van Zuydam NR, Meisinger C, Esko T, Mihailov E, Escher SA, Alver M, Moebus S, Morris AD, Virtamo J, Nikpay M, Olivieri O, Provost S, AlQarawi A, Robertson NR, Akinsansya KO, Reilly DF, Vogt TF, Yin W, Asselbergs FW, Kooperberg C, Jackson RD, Stahl E, Müller-Nurasyid M, Strauch K, Varga TV, Waldenberger M, Zeng L, Chowdhury R, Salomaa V, Ford I, Jukema JW, Amouyel P, Kontto J, Nordestgaard BG, Ferrières J, Saleheen D, Sattar N, Surendran P, Wagner A, Young R, Howson JM, Butterworth AS, Danesh J, Ardissino D, Bottinger EP, Erbel R, Franks PW, Girelli D, Hall AS, Hovingh GK, Kastrati A, Lieb W, Meitinger T, Kraus WE, Shah SH, McPherson R, Orho-Melander M, Melander O, Metspalu A, Palmer CN, Peters A, Rader DJ, Reilly MP, Loos RJ, Reiner AP, Roden DM, Tardif JC, Thompson JR, Wareham NJ, Watkins H, Willer CJ, Samani NJ, Schunkert H, Deloukas P, and Kathiresan S
- Subjects
- Case-Control Studies, Coronary Artery Disease epidemiology, Female, Gene Frequency, Genome-Wide Association Study, Humans, Male, Odds Ratio, Polymorphism, Single Nucleotide, Coronary Artery Disease genetics, Genetic Loci, Genetic Pleiotropy
- Abstract
Background: Genome-wide association studies have so far identified 56 loci associated with risk of coronary artery disease (CAD). Many CAD loci show pleiotropy; that is, they are also associated with other diseases or traits., Objectives: This study sought to systematically test if genetic variants identified for non-CAD diseases/traits also associate with CAD and to undertake a comprehensive analysis of the extent of pleiotropy of all CAD loci., Methods: In discovery analyses involving 42,335 CAD cases and 78,240 control subjects we tested the association of 29,383 common (minor allele frequency >5%) single nucleotide polymorphisms available on the exome array, which included a substantial proportion of known or suspected single nucleotide polymorphisms associated with common diseases or traits as of 2011. Suggestive association signals were replicated in an additional 30,533 cases and 42,530 control subjects. To evaluate pleiotropy, we tested CAD loci for association with cardiovascular risk factors (lipid traits, blood pressure phenotypes, body mass index, diabetes, and smoking behavior), as well as with other diseases/traits through interrogation of currently available genome-wide association study catalogs., Results: We identified 6 new loci associated with CAD at genome-wide significance: on 2q37 (KCNJ13-GIGYF2), 6p21 (C2), 11p15 (MRVI1-CTR9), 12q13 (LRP1), 12q24 (SCARB1), and 16q13 (CETP). Risk allele frequencies ranged from 0.15 to 0.86, and odds ratio per copy of the risk allele ranged from 1.04 to 1.09. Of 62 new and known CAD loci, 24 (38.7%) showed statistical association with a traditional cardiovascular risk factor, with some showing multiple associations, and 29 (47%) showed associations at p < 1 × 10
-4 with a range of other diseases/traits., Conclusions: We identified 6 loci associated with CAD at genome-wide significance. Several CAD loci show substantial pleiotropy, which may help us understand the mechanisms by which these loci affect CAD risk., (Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2017
- Full Text
- View/download PDF
33. Microenvironment-derived factors driving metastatic plasticity in melanoma.
- Author
-
Kim IS, Heilmann S, Kansler ER, Zhang Y, Zimmer M, Ratnakumar K, Bowman RL, Simon-Vermot T, Fennell M, Garippa R, Lu L, Lee W, Hollmann T, Xavier JB, and White RM
- Subjects
- Animals, CRISPR-Cas Systems genetics, Cell Differentiation genetics, Cell Proliferation genetics, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Humans, Melanoma genetics, Models, Biological, Neoplasm Metastasis, Phenotype, Zebrafish, Zebrafish Proteins metabolism, Cell Plasticity genetics, Melanoma pathology, Tumor Microenvironment genetics
- Abstract
Cellular plasticity is a state in which cancer cells exist along a reversible phenotypic spectrum, and underlies key traits such as drug resistance and metastasis. Melanoma plasticity is linked to phenotype switching, where the microenvironment induces switches between invasive/MITF
LO versus proliferative/MITFHI states. Since MITF also induces pigmentation, we hypothesize that macrometastatic success should be favoured by microenvironments that induce a MITFHI /differentiated/proliferative state. Zebrafish imaging demonstrates that after extravasation, melanoma cells become pigmented and enact a gene expression program of melanocyte differentiation. We screened for microenvironmental factors leading to phenotype switching, and find that EDN3 induces a state that is both proliferative and differentiated. CRISPR-mediated inactivation of EDN3, or its synthetic enzyme ECE2, from the microenvironment abrogates phenotype switching and increases animal survival. These results demonstrate that after metastatic dissemination, the microenvironment provides signals to promote phenotype switching and provide proof that targeting tumour cell plasticity is a viable therapeutic opportunity.- Published
- 2017
- Full Text
- View/download PDF
34. Linkage and Association Analysis Identifies TRAF1 Influencing Common Carotid Intima-Media Thickness.
- Author
-
Heßler N, Geisel MH, Coassin S, Erbel R, Heilmann S, Hennig F, Hoffmann B, Jöckel KH, Moebus S, Moskau-Hartmann S, Nürnberg G, Nürnberg P, Vens M, Klockgether T, Kronenberg F, Scherag A, and Ziegler A
- Subjects
- Adult, Aged, Female, Genetic Linkage, Genome-Wide Association Study, Germany, Humans, Male, Middle Aged, Nuclear Family, Atherosclerosis genetics, Carotid Intima-Media Thickness, TNF Receptor-Associated Factor 1 genetics
- Abstract
Background and Purpose: Carotid intima-media thickness is a marker for subclinical atherosclerosis that predicts subsequent clinical cardiovascular events. The aim of this study was to identify chromosomal loci with linkage or association to common carotid intima-media thickness., Methods: Nuclear families were recruited using the single parental proband sib-pair design. Genotype data were available for 546 individuals from 132 nuclear families of the Bonn IMT Family Study using the Affymetrix GeneChip Human Mapping 250K Sty chip. Multipoint logarithm of the odds (LOD) scores were determined with the quantitative trait locus statistic implemented in multipoint engine for rapid likelihood. Linkage analysis and family-based association tests were conducted. Data from 2471 German participants from the HNR (Heinz Nixdorf Recall) Study were used for subsequent replication., Results: Two new genomic regions with suggestive linkage (LOD>2) were identified on chromosome 4 (LOD=2.26) and on chromosome 17 (LOD=2.01). Previously reported linkage findings were replicated on chromosomes 13 and 14. Fifteen single nucleotide polymorhisms, located on chromosomes 4, 6, and 9, revealed P<10
-4 in the family-based association analyses. One of these signals was replicated in HNR (rs2416804, 1-sided P=1.60×10-3 , located in the gene TRAF1)., Conclusions: This study presents the first genome-wide linkage and association study of common carotid intima-media thickness in the German population. Alleles of rs2416804 in TRAF1 were identified as being linked and associated with carotid intima-media thickness. Further studies are needed to evaluate the contribution of this locus to the development of atherosclerosis., (© 2016 American Heart Association, Inc.)- Published
- 2016
- Full Text
- View/download PDF
35. Differential Expression between Human Dermal Papilla Cells from Balding and Non-Balding Scalps Reveals New Candidate Genes for Androgenetic Alopecia.
- Author
-
Chew EGY, Tan JHJ, Bahta AW, Ho BS, Liu X, Lim TC, Sia YY, Bigliardi PL, Heilmann S, Wan ACA, Nöthen MM, Philpott MP, and Hillmer AM
- Subjects
- Androgens metabolism, Biopsy, Carrier Proteins genetics, Cell Line, Cell Nucleus metabolism, Cluster Analysis, Gene Expression Profiling, Hair Follicle metabolism, Humans, Male, Membrane Proteins genetics, Neoplasm Proteins genetics, Nuclear Proteins genetics, Oligonucleotide Array Sequence Analysis, Promoter Regions, Genetic, Receptors, Androgen genetics, Scalp, Twist-Related Protein 1 genetics, Xedar Receptor, Alopecia genetics, Dermis cytology, Gene Expression Regulation, Skin cytology
- Abstract
Androgenetic alopecia (AGA) is a common heritable and androgen-dependent hair loss condition in men. Twelve genetic risk loci are known to date, but it is unclear which genes at these loci are relevant for AGA. Dermal papilla cells (DPCs) located in the hair bulb are the main site of androgen activity in the hair follicle. Widely used monolayer-cultured primary DPCs in hair-related studies often lack dermal papilla characteristics. In contrast, immortalized DPCs have high resemblance to intact dermal papilla. We derived immortalized human DPC lines from balding (BAB) and non-balding (BAN) scalp. Both BAB and BAN retained high proportions of dermal papilla signature gene and versican protein expression. We performed expression analysis of BAB and BAN and annotated AGA risk loci with differentially expressed genes. We found evidence for AR but not EDA2R as the candidate gene at the AGA risk locus on chromosome X. Further, our data suggest TWIST1 (twist family basic helix-loop-helix transcription factor 1) and SSPN (sarcospan) to be the functionally relevant AGA genes at the 7p21.1 and 12p12.1 risk loci, respectively. Down-regulated genes in BAB compared to BAN were highly enriched for vasculature-related genes, suggesting that deficiency of DPC from balding scalps in fostering vascularization around the hair follicle may contribute to the development of AGA., (Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
36. Prediction of male-pattern baldness from genotypes.
- Author
-
Liu F, Hamer MA, Heilmann S, Herold C, Moebus S, Hofman A, Uitterlinden AG, Nöthen MM, van Duijn CM, Nijsten TE, and Kayser M
- Subjects
- Adult, Aged, Case-Control Studies, Genetic Loci, Humans, Male, Middle Aged, Polymorphism, Single Nucleotide, Alopecia genetics, Genotype
- Abstract
The global demand for products that effectively prevent the development of male-pattern baldness (MPB) has drastically increased. However, there is currently no established genetic model for the estimation of MPB risk. We conducted a prediction analysis using single-nucleotide polymorphisms (SNPs) identified from previous GWASs of MPB in a total of 2725 German and Dutch males. A logistic regression model considering the genotypes of 25 SNPs from 12 genomic loci demonstrates that early-onset MPB risk is predictable at an accuracy level of 0.74 when 14 SNPs were included in the model, and measured using the area under the receiver-operating characteristic curves (AUC). Considering age as an additional predictor, the model can predict normal MPB status in middle-aged and elderly individuals at a slightly lower accuracy (AUC 0.69-0.71) when 6-11 SNPs were used. A variance partitioning analysis suggests that 55.8% of early-onset MPB genetic liability can be explained by common autosomal SNPs and 23.3% by X-chromosome SNPs. For normal MPB status in elderly individuals, the proportion of explainable variance is lower (42.4% for autosomal and 9.8% for X-chromosome SNPs). The gap between GWAS findings and the variance partitioning results could be explained by a large body of common DNA variants with small effects that will likely be identified in GWAS of increased sample sizes. Although the accuracy obtained here has not reached a clinically desired level, our model was highly informative for up to 19% of Europeans, thus may assist decision making on early MPB intervention actions and in forensic investigations.
- Published
- 2016
- Full Text
- View/download PDF
37. Search for new loci and low-frequency variants influencing glioma risk by exome-array analysis.
- Author
-
Kinnersley B, Kamatani Y, Labussière M, Wang Y, Galan P, Mokhtari K, Delattre JY, Gousias K, Schramm J, Schoemaker MJ, Swerdlow A, Fleming SJ, Herms S, Heilmann S, Nöthen MM, Simon M, Sanson M, Lathrop M, and Houlston RS
- Subjects
- Algorithms, Amino Acyl-tRNA Synthetases genetics, BRCA2 Protein genetics, Case-Control Studies, Female, Humans, Isocitrate Dehydrogenase genetics, Male, Middle Aged, Brain Neoplasms genetics, Exome, Genetic Loci, Genotyping Techniques methods, Glioma genetics, Polymorphism, Single Nucleotide
- Abstract
To identify protein-altering variants (PAVs) for glioma, we analysed Illumina HumanExome BeadChip exome-array data on 1882 glioma cases and 8079 controls from three independent European populations. In addition to single-variant tests we incorporated information on the predicted functional consequences of PAVs and analysed sets of genes with a higher likelihood of having a role in glioma on the basis of the profile of somatic mutations documented by large-scale sequencing initiatives. Globally there was a strong relationship between effect size and PAVs predicted to be damaging (P=2.29 × 10(-49)); however, these variants which are most likely to impact on risk, are rare (MAF<5%). Although no single variant showed an association which was statistically significant at the genome-wide threshold a number represented promising associations - BRCA2:c.9976A>T, p.(Lys3326Ter), which has been shown to influence breast and lung cancer risk (odds ratio (OR)=2.3, P=4.00 × 10(-4) for glioblastoma (GBM)) and IDH2:c.782G>A, p.(Arg261His) (OR=3.21, P=7.67 × 10(-3), for non-GBM). Additionally, gene burden tests revealed a statistically significant association for HARS2 and risk of GBM (P=2.20 × 10(-6)). Genome scans of low-frequency PAVs represent a complementary strategy to identify disease-causing variants compared with scans based on tagSNPs. Strategies to lessen the multiple testing burden by restricting analysis to PAVs with higher priors affords an opportunity to maximise study power.
- Published
- 2016
- Full Text
- View/download PDF
38. A Quantitative System for Studying Metastasis Using Transparent Zebrafish.
- Author
-
Heilmann S, Ratnakumar K, Langdon E, Kansler E, Kim I, Campbell NR, Perry E, McMahon A, Kaufman C, van Rooijen E, Lee W, Iacobuzio-Donahue C, Hynes R, Zon L, Xavier J, and White RM
- Subjects
- Algorithms, Animals, Animals, Genetically Modified, Cell Line, Tumor, Disease Models, Animal, Gene Expression Profiling, Melanoma genetics, Melanoma metabolism, Melanoma pathology, Mutation, Neoplasm Metastasis, Neoplasms genetics, Neoplasms metabolism, Transcriptome, Models, Biological, Neoplasms pathology, Zebrafish
- Abstract
Metastasis is the defining feature of advanced malignancy, yet remains challenging to study in laboratory environments. Here, we describe a high-throughput zebrafish system for comprehensive, in vivo assessment of metastatic biology. First, we generated several stable cell lines from melanomas of transgenic mitfa-BRAF(V600E);p53(-/-) fish. We then transplanted the melanoma cells into the transparent casper strain to enable highly quantitative measurement of the metastatic process at single-cell resolution. Using computational image analysis of the resulting metastases, we generated a metastasis score, μ, that can be applied to quantitative comparison of metastatic capacity between experimental conditions. Furthermore, image analysis also provided estimates of the frequency of metastasis-initiating cells (∼1/120,000 cells). Finally, we determined that the degree of pigmentation is a key feature defining cells with metastatic capability. The small size and rapid generation of progeny combined with superior imaging tools make zebrafish ideal for unbiased high-throughput investigations of cell-intrinsic or microenvironmental modifiers of metastasis. The approaches described here are readily applicable to other tumor types and thus serve to complement studies also employing murine and human cell culture systems., (©2015 American Association for Cancer Research.)
- Published
- 2015
- Full Text
- View/download PDF
39. Genome-wide association study identifies multiple susceptibility loci for glioma.
- Author
-
Kinnersley B, Labussière M, Holroyd A, Di Stefano AL, Broderick P, Vijayakrishnan J, Mokhtari K, Delattre JY, Gousias K, Schramm J, Schoemaker MJ, Fleming SJ, Herms S, Heilmann S, Schreiber S, Wichmann HE, Nöthen MM, Swerdlow A, Lathrop M, Simon M, Bondy M, Sanson M, and Houlston RS
- Subjects
- Female, Genotype, Glioma classification, Humans, Male, Middle Aged, Genetic Predisposition to Disease, Genome-Wide Association Study, Glioma genetics
- Abstract
Previous genome-wide association studies (GWASs) have shown that common genetic variation contributes to the heritable risk of glioma. To identify new glioma susceptibility loci, we conducted a meta-analysis of four GWAS (totalling 4,147 cases and 7,435 controls), with imputation using 1000 Genomes and UK10K Project data as reference. After genotyping an additional 1,490 cases and 1,723 controls we identify new risk loci for glioblastoma (GBM) at 12q23.33 (rs3851634, near POLR3B, P=3.02 × 10(-9)) and non-GBM at 10q25.2 (rs11196067, near VTI1A, P=4.32 × 10(-8)), 11q23.2 (rs648044, near ZBTB16, P=6.26 × 10(-11)), 12q21.2 (rs12230172, P=7.53 × 10(-11)) and 15q24.2 (rs1801591, near ETFA, P=5.71 × 10(-9)). Our findings provide further insights into the genetic basis of the different glioma subtypes.
- Published
- 2015
- Full Text
- View/download PDF
40. Why do bacteria regulate public goods by quorum sensing?-How the shapes of cost and benefit functions determine the form of optimal regulation.
- Author
-
Heilmann S, Krishna S, and Kerr B
- Abstract
Many bacteria secrete compounds which act as public goods. Such compounds are often under quorum sensing (QS) regulation, yet it is not understood exactly when bacteria may gain from having a public good under QS regulation. Here, we show that the optimal public good production rate per cell as a function of population size (the optimal production curve, OPC) depends crucially on the cost and benefit functions of the public good and that the OPC will fall into one of two categories: Either it is continuous or it jumps from zero discontinuously at a critical population size. If, e.g., the public good has accelerating returns and linear cost, then the OPC is discontinuous and the best strategy thus to ramp up production sharply at a precise population size. By using the example of public goods with accelerating and diminishing returns (and linear cost) we are able to determine how the two different categories of OPSs can best be matched by production regulated through a QS signal feeding back on its own production. We find that the optimal QS parameters are different for the two categories and specifically that public goods which provide accelerating returns, call for stronger positive signal feedback.
- Published
- 2015
- Full Text
- View/download PDF
41. PLD3 in non-familial Alzheimer's disease.
- Author
-
Heilmann S, Drichel D, Clarimon J, Fernández V, Lacour A, Wagner H, Thelen M, Hernández I, Fortea J, Alegret M, Blesa R, Mauleón A, Roca MR, Kornhuber J, Peters O, Heun R, Frölich L, Hüll M, Heneka MT, Rüther E, Riedel-Heller S, Scherer M, Wiltfang J, Jessen F, Becker T, Tárraga L, Boada M, Maier W, Lleó A, Ruiz A, Nöthen MM, and Ramirez A
- Subjects
- Female, Humans, Male, Alzheimer Disease genetics, Genetic Predisposition to Disease genetics, Genetic Variation genetics, Phospholipase D genetics
- Published
- 2015
- Full Text
- View/download PDF
42. Genome-wide association study and meta-analysis identify ISL1 as genome-wide significant susceptibility gene for bladder exstrophy.
- Author
-
Draaken M, Knapp M, Pennimpede T, Schmidt JM, Ebert AK, Rösch W, Stein R, Utsch B, Hirsch K, Boemers TM, Mangold E, Heilmann S, Ludwig KU, Jenetzky E, Zwink N, Moebus S, Herrmann BG, Mattheisen M, Nöthen MM, Ludwig M, and Reutter H
- Subjects
- Animals, Case-Control Studies, Humans, LIM-Homeodomain Proteins metabolism, Mice, Transcription Factors metabolism, Bladder Exstrophy genetics, Genome-Wide Association Study, LIM-Homeodomain Proteins genetics, Transcription Factors genetics
- Abstract
The bladder exstrophy-epispadias complex (BEEC) represents the severe end of the uro-rectal malformation spectrum, and is thought to result from aberrant embryonic morphogenesis of the cloacal membrane and the urorectal septum. The most common form of BEEC is isolated classic bladder exstrophy (CBE). To identify susceptibility loci for CBE, we performed a genome-wide association study (GWAS) of 110 CBE patients and 1,177 controls of European origin. Here, an association was found with a region of approximately 220kb on chromosome 5q11.1. This region harbors the ISL1 (ISL LIM homeobox 1) gene. Multiple markers in this region showed evidence for association with CBE, including 84 markers with genome-wide significance. We then performed a meta-analysis using data from a previous GWAS by our group of 98 CBE patients and 526 controls of European origin. This meta-analysis also implicated the 5q11.1 locus in CBE risk. A total of 138 markers at this locus reached genome-wide significance in the meta-analysis, and the most significant marker (rs9291768) achieved a P value of 2.13 × 10-12. No other locus in the meta-analysis achieved genome-wide significance. We then performed murine expression analyses to follow up this finding. Here, Isl1 expression was detected in the genital region within the critical time frame for human CBE development. Genital regions with Isl1 expression included the peri-cloacal mesenchyme and the urorectal septum. The present study identified the first genome-wide significant locus for CBE at chromosomal region 5q11.1, and provides strong evidence for the hypothesis that ISL1 is the responsible candidate gene in this region.
- Published
- 2015
- Full Text
- View/download PDF
43. Immunochip-based analysis: high-density genotyping of immune-related loci sheds further light on the autoimmune genetic architecture of alopecia areata.
- Author
-
Redler S, Angisch M, Heilmann S, Wolf S, Barth S, Basmanav BF, Giehl KA, Hanneken S, Eigelshoven S, Mangold E, Kruse R, Blaumeiser B, Böhm M, Knapp M, Garcia Bartels N, Lutz G, Wolff H, Blume-Peytavi U, Nöthen MM, Becker T, and Betz RC
- Subjects
- Adolescent, Adult, Aged, Alleles, Case-Control Studies, Child, Child, Preschool, Female, HLA Antigens genetics, Humans, Logistic Models, Male, Middle Aged, Polymorphism, Single Nucleotide genetics, White People genetics, Young Adult, Alopecia Areata genetics, Autoimmune Diseases genetics, Genetic Loci genetics, Genotype, Protein Array Analysis
- Published
- 2015
- Full Text
- View/download PDF
44. Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci.
- Author
-
Betz RC, Petukhova L, Ripke S, Huang H, Menelaou A, Redler S, Becker T, Heilmann S, Yamany T, Duvic M, Hordinsky M, Norris D, Price VH, Mackay-Wiggan J, de Jong A, DeStefano GM, Moebus S, Böhm M, Blume-Peytavi U, Wolff H, Lutz G, Kruse R, Bian L, Amos CI, Lee A, Gregersen PK, Blaumeiser B, Altshuler D, Clynes R, de Bakker PIW, Nöthen MM, Daly MJ, and Christiano AM
- Subjects
- Adaptor Proteins, Signal Transducing, Alleles, Animals, Bcl-2-Like Protein 11, Case-Control Studies, Female, Genome-Wide Association Study, Humans, Intracellular Signaling Peptides and Proteins, Male, Mice, Microscopy, Fluorescence, Oligonucleotide Array Sequence Analysis, Phenotype, Principal Component Analysis, Protein Conformation, Skin metabolism, Alopecia Areata genetics, Apoptosis Regulatory Proteins genetics, Ataxin-2 genetics, Genetic Predisposition to Disease, HLA Antigens genetics, Membrane Proteins genetics, Polymorphism, Single Nucleotide, Proteins genetics, Proto-Oncogene Proteins genetics
- Abstract
Alopecia areata (AA) is a prevalent autoimmune disease with 10 known susceptibility loci. Here we perform the first meta-analysis of research on AA by combining data from two genome-wide association studies (GWAS), and replication with supplemented ImmunoChip data for a total of 3,253 cases and 7,543 controls. The strongest region of association is the major histocompatibility complex, where we fine-map four independent effects, all implicating human leukocyte antigen-DR as a key aetiologic driver. Outside the major histocompatibility complex, we identify two novel loci that exceed the threshold of statistical significance, containing ACOXL/BCL2L11(BIM) (2q13); GARP (LRRC32) (11q13.5), as well as a third nominally significant region SH2B3(LNK)/ATXN2 (12q24.12). Candidate susceptibility gene expression analysis in these regions demonstrates expression in relevant immune cells and the hair follicle. We integrate our results with data from seven other autoimmune diseases and provide insight into the alignment of AA within these disorders. Our findings uncover new molecular pathways disrupted in AA, including autophagy/apoptosis, transforming growth factor beta/Tregs and JAK kinase signalling, and support the causal role of aberrant immune processes in AA.
- Published
- 2015
- Full Text
- View/download PDF
45. SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease.
- Author
-
Ramirez A, van der Flier WM, Herold C, Ramonet D, Heilmann S, Lewczuk P, Popp J, Lacour A, Drichel D, Louwersheimer E, Kummer MP, Cruchaga C, Hoffmann P, Teunissen C, Holstege H, Kornhuber J, Peters O, Naj AC, Chouraki V, Bellenguez C, Gerrish A, Heun R, Frölich L, Hüll M, Buscemi L, Herms S, Kölsch H, Scheltens P, Breteler MM, Rüther E, Wiltfang J, Goate A, Jessen F, Maier W, Heneka MT, Becker T, and Nöthen MM
- Subjects
- Aged, Alzheimer Disease cerebrospinal fluid, Alzheimer Disease pathology, Amyloid beta-Peptides cerebrospinal fluid, Apolipoprotein E4 cerebrospinal fluid, Cognition, Female, Gene Expression Regulation, Genome-Wide Association Study, Humans, Male, Nuclear Proteins cerebrospinal fluid, Peptide Fragments cerebrospinal fluid, Phosphorylation, RNA-Binding Proteins cerebrospinal fluid, Serine-Arginine Splicing Factors, Signal Transduction, tau Proteins cerebrospinal fluid, Alzheimer Disease genetics, Amyloid beta-Peptides genetics, Apolipoprotein E4 genetics, Nuclear Proteins genetics, Peptide Fragments genetics, Polymorphism, Single Nucleotide, RNA-Binding Proteins genetics, tau Proteins genetics
- Abstract
Cerebrospinal fluid amyloid-beta 1-42 (Aβ1-42) and phosphorylated Tau at position 181 (pTau181) are biomarkers of Alzheimer's disease (AD). We performed an analysis and meta-analysis of genome-wide association study data on Aβ1-42 and pTau181 in AD dementia patients followed by independent replication. An association was found between Aβ1-42 level and a single-nucleotide polymorphism in SUCLG2 (rs62256378) (P = 2.5×10(-12)). An interaction between APOE genotype and rs62256378 was detected (P = 9.5 × 10(-5)), with the strongest effect being observed in APOE-ε4 noncarriers. Clinically, rs62256378 was associated with rate of cognitive decline in AD dementia patients (P = 3.1 × 10(-3)). Functional microglia experiments showed that SUCLG2 was involved in clearance of Aβ1-42., (© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2014
- Full Text
- View/download PDF
46. Dissecting the genotype in syndromic intellectual disability using whole exome sequencing in addition to genome-wide copy number analysis.
- Author
-
Classen CF, Riehmer V, Landwehr C, Kosfeld A, Heilmann S, Scholz C, Kabisch S, Engels H, Tierling S, Zivicnjak M, Schacherer F, Haffner D, and Weber RG
- Subjects
- Chromosome Deletion, Cytoskeletal Proteins genetics, Female, GTPase-Activating Proteins genetics, Gene Dosage, Humans, Male, Mutation, Missense, Nuclear Proteins genetics, Chromosomes, Human, Pair 14 genetics, Chromosomes, Human, Pair 22 genetics, Cognition Disorders genetics, Exome, Genetic Diseases, Inborn genetics, Genome-Wide Association Study, Genotype
- Abstract
When a known microimbalance affecting multiple genes is detected in a patient with syndromic intellectual disability, it is usually presumed causative for all observed features. Whole exome sequencing (WES) allows questioning this assumption. In this study of three families with children affected by unexplained syndromic intellectual disability, genome-wide copy number and subsequent analyses revealed a de novo maternal 1.1 Mb microdeletion in the 14q32 imprinted region causing a paternal UPD(14)-like phenotype, and two inherited 22q11.21 microduplications of 2.5 or 2.8 Mb. In patient 1 carrying the 14q32 microdeletion, tall stature and renal malformation were unexplained by paternal UPD(14), and there was no altered DLK1 expression or unexpected methylation status. By WES and filtering with a mining tool, a novel FBN1 missense variant was found in patient 1 and his mother, who both showed clinical features of Marfan syndrome by thorough anthropometric assessment, and a novel EYA1 missense variant as a probable cause of the renal malformation in the patient. In patient 2 with the 22q11.21 microduplication syndrome, skin hypo- and hyperpigmentation and two malignancies were only partially explained. By WES, compound heterozygous BLM stop founder mutations were detected causing Bloom syndrome. In male patient 3 carrying a 22q11.21 microduplication inherited from his unaffected father, WES identified a novel missense variant in the OPHN1 X-linked intellectual disability gene inherited from the unaffected mother as a possible additional cause for developmental delay. Thus, WES seems warranted in patients carrying microdeletions or microduplications, who have unexplained clinical features or microimbalances inherited from an unaffected parent.
- Published
- 2013
- Full Text
- View/download PDF
47. Androgenetic alopecia: identification of four genetic risk loci and evidence for the contribution of WNT signaling to its etiology.
- Author
-
Heilmann S, Kiefer AK, Fricker N, Drichel D, Hillmer AM, Herold C, Tung JY, Eriksson N, Redler S, Betz RC, Li R, Kárason A, Nyholt DR, Song K, Vermeulen SH, Kanoni S, Dedoussis G, Martin NG, Kiemeney LA, Mooser V, Stefansson K, Richards JB, Becker T, Brockschmidt FF, Hinds DA, and Nöthen MM
- Subjects
- Adult, Alopecia etiology, Alopecia metabolism, Cholestanetriol 26-Monooxygenase genetics, Chromosomes, Human, Pair 12, Chromosomes, Human, Pair 2, Chromosomes, Human, Pair 3, Chromosomes, Human, Pair 5, Frizzled Receptors genetics, Genetic Predisposition to Disease epidemiology, Genetic Predisposition to Disease genetics, Genome-Wide Association Study, Humans, Male, Middle Aged, Polymorphism, Single Nucleotide genetics, Risk Factors, White People genetics, White People statistics & numerical data, Wnt3 Protein genetics, Alopecia epidemiology, Alopecia genetics, Wnt Proteins genetics, Wnt Signaling Pathway physiology
- Abstract
The pathogenesis of androgenetic alopecia (AGA, male-pattern baldness) is driven by androgens, and genetic predisposition is the major prerequisite. Candidate gene and genome-wide association studies have reported that single-nucleotide polymorphisms (SNPs) at eight different genomic loci are associated with AGA development. However, a significant fraction of the overall heritable risk still awaits identification. Furthermore, the understanding of the pathophysiology of AGA is incomplete, and each newly associated locus may provide novel insights into contributing biological pathways. The aim of this study was to identify unknown AGA risk loci by replicating SNPs at the 12 genomic loci that showed suggestive association (5 × 10(-8)
- Published
- 2013
- Full Text
- View/download PDF
48. Acyl-homoserine lactone-dependent eavesdropping promotes competition in a laboratory co-culture model.
- Author
-
Chandler JR, Heilmann S, Mittler JE, and Greenberg EP
- Subjects
- Anti-Bacterial Agents metabolism, Benzopyrans metabolism, Burkholderia growth & development, Chromobacterium growth & development, Coculture Techniques, Indoles metabolism, Microbial Sensitivity Tests, Signal Transduction, Soil Microbiology, Acyl-Butyrolactones metabolism, Antibiosis, Burkholderia physiology, Chromobacterium physiology, Quorum Sensing
- Abstract
Many Proteobacteria use acyl-homoserine lactone (AHL)-mediated quorum sensing to activate the production of antibiotics at high cell density. Extracellular factors like antibiotics can be considered public goods shared by individuals within a group. Quorum-sensing control of antibiotic production may be important for protecting a niche or competing for limited resources in mixed bacterial communities. To begin to investigate the role of quorum sensing in interspecies competition, we developed a dual-species co-culture model using the soil saprophytes Burkholderia thailandensis (Bt) and Chromobacterium violaceum (Cv). These bacteria require quorum sensing to activate the production of antimicrobial factors that inhibit growth of the other species. We demonstrate that quorum-sensing-dependent antimicrobials can provide a competitive advantage to either Bt or Cv by inhibiting growth of the other species in co-culture. Although the quorum-sensing signals differ for each species, we show that the promiscuous signal receptor encoded by Cv can sense signals produced by Bt, and that this ability to eavesdrop on Bt can provide Cv an advantage in certain situations. We use an in silico approach to investigate the effect of eavesdropping in competition, and show conditions where early activation of antibiotic production resulting from eavesdropping can promote competitiveness. Our work supports the idea that quorum sensing is important for interspecies competition and that promiscuous signal receptors allow eavesdropping on competitors in mixed microbial habitats.
- Published
- 2012
- Full Text
- View/download PDF
49. Coexistence of phage and bacteria on the boundary of self-organized refuges.
- Author
-
Heilmann S, Sneppen K, and Krishna S
- Subjects
- Quorum Sensing physiology, Bacteria virology, Bacterial Physiological Phenomena, Bacteriophages physiology, Biological Evolution, Ecosystem, Models, Biological
- Abstract
Bacteriophage are voracious predators of bacteria and a major determinant in shaping bacterial life strategies. Many phage species are virulent, meaning that infection leads to certain death of the host and immediate release of a large batch of phage progeny. Despite this apparent voraciousness, bacteria have stably coexisted with virulent phages for eons. Here, using individual-based stochastic spatial models, we study the conditions for achieving coexistence on the edge between two habitats, one of which is a bacterial refuge with conditions hostile to phage whereas the other is phage friendly. We show how bacterial density-dependent, or quorum-sensing, mechanisms such as the formation of biofilm can produce such refuges and edges in a self-organized manner. Coexistence on these edges exhibits the following properties, all of which are observed in real phage-bacteria ecosystems but difficult to achieve together in nonspatial ecosystem models: (i) highly efficient virulent phage with relatively long lifetimes, high infection rates and large burst sizes; (ii) large, stable, and high-density populations of phage and bacteria; (iii) a fast turnover of both phage and bacteria; and (iv) stability over evolutionary timescales despite imbalances in the rates of phage vs. bacterial evolution.
- Published
- 2012
- Full Text
- View/download PDF
50. Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases.
- Author
-
Li R, Brockschmidt FF, Kiefer AK, Stefansson H, Nyholt DR, Song K, Vermeulen SH, Kanoni S, Glass D, Medland SE, Dimitriou M, Waterworth D, Tung JY, Geller F, Heilmann S, Hillmer AM, Bataille V, Eigelshoven S, Hanneken S, Moebus S, Herold C, den Heijer M, Montgomery GW, Deloukas P, Eriksson N, Heath AC, Becker T, Sulem P, Mangino M, Vollenweider P, Spector TD, Dedoussis G, Martin NG, Kiemeney LA, Mooser V, Stefansson K, Hinds DA, Nöthen MM, and Richards JB
- Subjects
- Adult, Aged, Alleles, Fertility genetics, Genetic Predisposition to Disease, Genotype, Haplotypes, Humans, Male, Middle Aged, Polymorphism, Single Nucleotide, Risk Factors, Alopecia genetics, Genome-Wide Association Study, Parkinson Disease genetics
- Abstract
Androgenetic alopecia (AGA) is a highly heritable condition and the most common form of hair loss in humans. Susceptibility loci have been described on the X chromosome and chromosome 20, but these loci explain a minority of its heritable variance. We conducted a large-scale meta-analysis of seven genome-wide association studies for early-onset AGA in 12,806 individuals of European ancestry. While replicating the two AGA loci on the X chromosome and chromosome 20, six novel susceptibility loci reached genome-wide significance (p = 2.62×10⁻⁹-1.01×10⁻¹²). Unexpectedly, we identified a risk allele at 17q21.31 that was recently associated with Parkinson's disease (PD) at a genome-wide significant level. We then tested the association between early-onset AGA and the risk of PD in a cross-sectional analysis of 568 PD cases and 7,664 controls. Early-onset AGA cases had significantly increased odds of subsequent PD (OR = 1.28, 95% confidence interval: 1.06-1.55, p = 8.9×10⁻³). Further, the AGA susceptibility alleles at the 17q21.31 locus are on the H1 haplotype, which is under negative selection in Europeans and has been linked to decreased fertility. Combining the risk alleles of six novel and two established susceptibility loci, we created a genotype risk score and tested its association with AGA in an additional sample. Individuals in the highest risk quartile of a genotype score had an approximately six-fold increased risk of early-onset AGA [odds ratio (OR) = 5.78, p = 1.4×10⁻⁸⁸]. Our results highlight unexpected associations between early-onset AGA, Parkinson's disease, and decreased fertility, providing important insights into the pathophysiology of these conditions., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.